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To my mother Linda 
ABSTRACT 
The comet assay is an established, sensitive method extensively used in biomonitoring 
studies. The methods’ advantages include; a) only a small cell sample is required, b) 
possibility to measure damage in practically any cell type, c) ability to measure 
heterogeneity in response within a cell population, d) relatively fast and economical 
procedure, and e) various applications of the method, which allow measurement of a 
range of different DNA lesions as well as DNA repair. 
Several guidelines for the comet assay have been published, but no standardised 
protocol exists as yet. There are considerable differences between the protocols used by 
different research groups, which negatively affect inter-laboratory comparisons of 
results. Several experts in the field have highlighted the need for multi-laboratory, 
international validation studies, to assess intra- and inter-laboratory reproducibility and 
to investigate sources of variability in the results. 
The papers in this thesis can be divided into two parts; one part that deals with 
international inter-laboratory validation studies and methodological aspects of the 
comet assay (paper I-III), and the other part covers a human intervention study with 
antioxidant capsules consisting of many different antioxidants in low doses for which 
the comet assay has been applied (paper IV-V). 
The inter-laboratory validation trials in papers I-II indicate that the participants can 
detect dose-responses of both DNA breaks and oxidatively damaged DNA in coded 
cells, but that there is a large inter-laboratory variation in the reported values. This 
variation can in part be explained by differences in comet assay protocols and in image 
analysis. The inter-laboratory variation was decreased, but not completely removed, by 
calibration with ionising radiation. 
In paper III we verified that several protocol steps significantly affected the outcome of 
the comet assay, including a) density of the agarose gel, b) extent of enzymatic 
incubation, c) duration of alkaline treatment, and d) time of electrophoresis, as well as 
the strength of the electric field applied. 
In a parallel placebo-controlled, double-blind intervention study, overweight middle-
aged men were supplemented for six weeks with a multivitamin supplement consisting 
of a range of antioxidants in doses resembling those achieved by a healthy diet (paper 
IV-V). In spite of elevated levels of seven out of eight measured antioxidants in the 
blood, the intervention did not affect the level of oxidation of lipids or DNA. Many 
intervention studies with good design report similar null findings. It is preferred to 
consume antioxidants through a healthy diet, and dietary supplements are not 
recommended for cancer prevention.  
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LIST OF ABBREVIATIONS 
A adenine 
A549 human type II alveolar epithelial cell line 
AlkA  3-methyladenine glycosylase II 
ALS alkali-labile sites 
AP sites apurinic and apyrimidinic sites 
ATBC α-tocopherol, β-carotene cancer prevention study 
a.u. arbitrary units 
bp  base pair 
BER  base excision repair 
C cytosine 
CARET the β-carotene and retinol efficacy trial 
CKD  chronic kidney disease 
COMICS comet assay and cell array for fast and efficient genotoxicity testing 
CV coefficient of variation 
dG 2’-deoxyguanosine 
DAPI  4’,6-diamidino-2-phenylindole 
DMSO dimethyl sulfoxide 
DNA  deoxyribonucleic acid 
DNA breaks includes DNA strand breaks and alkali-labile sites 
EC  electrochemical detection 
ECNIS Environmental Cancer Risk, Nutrition and Individual Susceptibility 
ECVAG the European Comet assay Validation Group 
EndoIII  endonuclease III 
ESCODD the European Standards Committee on Oxidative DNA Damage 
EtBr  ethidium bromide 
FISH  fluorescent in situ hybridisation 
Fpg  formamido pyrimidine DNA glycosylase 
G  guanine 
GC gas chromatography 
Gy gray 
H2O2  hydrogen peroxide 
HD hemodialysis 
HeLa  a human transformed epithelial cell line 
HPLC high performance liquid chromatography 
LMP  low melting point 
MDA malondialdehyde 
MS mass spectrometry 
NER  nucleotide excision repair 
NHANES national health and nutrition examination survey 
Ogg1  8-oxoguanine DNA glycosylase 
8-oxodG 8-oxo-7,8-dihydro-2’-deoxyguanosine 
8-iso-PGF2α 8-isoprostaglandin F2α 
PBMC peripheral blood mononuclear cells  
PBS  phosphate buffered saline 
PI  propidium iodide 
Ro  photosensitiser Ro 19-8022 
ROS  reactive oxygen species 
SELECT the selenium and vitamin E cancer prevention trial 
SNP  single nucleotide polymorphism 
SOD  superoxide dismutase 
SU.VI.MAX the supplémentation en vitamines et minéraux antioxydants study 
T thymine 
TBA thiobarbituric acid 
THP-1 human acute monocytic leukaemia cell line 
UNG uracil-DNA glycosylase 
U uracil 
UV  ultraviolet (light) 
YOYO-1 YOYO®-1 iodide 
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1 INTRODUCTION  
The human genome, deoxyribonucleic acid (DNA), can be oxidatively modified by 
many different compounds, but reactive oxygen species (ROS) are generally regarded 
to be the most important cause of oxidation. An increased production of ROS has been 
suggested to influence the development of more than a hundred human diseases 1, and 
they seem to be particularly fundamental to the development of cancer and 
neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease 2. 
ROS, are chemically reactive molecules containing oxygen, which also include free 
radicals, and are formed via many pathways in the normal metabolism of aerobic 
organisms. Processes involved in the production of ROS include endogenous sources 
such as phagocytic defence functions, leakage from mitochondrial respiration, 
enzymatic metabolism and the catalytic activity of transition metals 3. In addition, ROS 
can be created by exogenous sources such as environmental and occupational exposure 
to radiation, chemicals, particles etc. Cells protect themselves against ROS by 
antioxidants, e.g. phytochemicals and vitamins, antioxidant enzymes, e.g. superoxide 
dismutase (SOD), catalase, glutathione peroxidase, repair mechanisms and adaptation 
(changes in expression of protective genes) 3. In addition, DNA is also protected 
through its supercoiled structure and histones. 
 
Oxidative stress has been defined as a disturbance in the pro-oxidant-antioxidant 
balance in favour of the former 4, leading to potential damage; i.e. the level of oxidising 
agents (primarily ROS) overwhelm the protective antioxidant defence systems and 
repair capacity of the cell. ROS are short-lived and therefore complicated to measure, 
especially in vivo. However, analysis of sufficiently stable end-products from oxidation 
processes, such as oxidatively damaged lipids, proteins and DNA, can give an estimate 
of the level of oxidative stress in cells 5.  
 
Environmental and occupational genotoxins can damage DNA in many different ways 
creating a range of DNA lesions such as oxidation damage, alkylation damage, base 
loss, DNA cross-links, covalent bonding of bulky DNA adducts etc. Many different 
types of DNA lesions are used as indicators of biological states or processes, 
subsequently referred to as biomarkers, and provide valuable information about 
exposure to damaging or protective agents, individual susceptibility, early stages of 
diseases etc. The most frequently measured biomarker for oxidatively damaged DNA is 
8-oxoguanine, which was discovered in 1984 by Kasai and Nishimura 6. The great 
interest in this biomarker is attributed to that it is believed to be important in 
carcinogenesis 7. 8-oxoguanine, one of the most abundant DNA lesions, causes 
mutations by inducing guanine-cytosine (G-C) to thymine-adenine (T-A) transversions. 
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8-oxoguanine has been studied extensively and there is a range of different methods 
available to measure this lesion.  
 
The comet assay is a method with which several biomarkers of exposure (reflecting the 
biologically effective dose) can be measured 8. The alkaline comet assay is an 
established, sensitive method extensively used in genetic toxicology, which in its basic 
form measures DNA breaks, i.e. strand breaks and alkali-labile sites (ALS), but can 
also be modified to measure a wider range of different lesions. Specific types of DNA 
lesions can be measured by using lesion-specific repair enzymes 9, such as formamido 
pyrimidine DNA glycosylase (Fpg) 10, endonuclease III (EndoIII) 11, human 8-
oxoguanine DNA glycosylase (hOgg1) 12, 3-methyladenine glycosylase II (AlkA) 13, 
T4 endonuclease V 14, 15 and uracil-DNA glycosylase (UNG) 16, which enables 
measurement of oxidatively damaged bases, alkylated bases, cyclobutane pyrimidine 
dimers, and misincorporated uracil. Recently, the comet assay has been modified to 
measure the DNA repair capacity of cells; i.e. base excision repair (BER) of mainly 8-
oxoguanine induced by the photosensitiser Ro 19-8022 (Ro) and visible light 17 or 
nucleotide excision repair (NER) of bulky DNA adducts 18, DNA damage induced by 
ultraviolet (UV) C light 19, and DNA cross-links 20. The kinetics of repair of DNA 
damage can also be estimated by exposure to different agents ex vivo, e.g. hydrogen 
peroxide (H2O2), and monitoring the rejoining of strand breaks or repair of DNA 
lesions. Other modifications of the comet assay allow the detection of DNA-DNA 
cross-links 21, and gene-specific DNA damage in combination with the fluorescent in 
situ hybridisation (FISH) methodology 22. The many applications of the comet assay 
together with the a) low number of cells required, b) ability to measure heterogeneity in 
sensitivity or response between cells, c) sensitivity in detecting low levels of DNA 
damage, and, d) possibility to measure damage in practically any eukaryotic cell type 
are some of the reasons for the assay’s increasing popularity 23. Figure 1 shows the 
amount of published comet papers each year over the last 20 years. Today, the comet 
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Figure 1. The amount of scientific articles published each year during the last 20 years 
(based on a PubMed search of the “comet assay” 2011-08-10).  
 
 
The comet assay is widely used in in vitro studies using cultured cells and in in vivo 
studies where DNA lesions can be measured in any eukaryotic cell type where a single 
cell suspension can be obtained. Since a relatively small amount of cells are required 
for analysis, the method is particularly suitable for in vivo studies. One important field 
where comet assay can be applied is in intervention studies assessing the impact of 
nutrition. In humans, the assay is mainly applied on peripheral blood mononuclear cells 
(PBMC). The comet assay has been shown to be a highly sensitive method to identify 
carcinogens and non-carcinogens 24, 25. Although the range of detection is rather narrow 
for the assay, approximately a hundred to several thousand breaks, it conveniently 
covers physiologically relevant levels of damage, ranging from the normal background 
levels of damage and damage levels induced by non-lethal doses of damaging agents 26. 
 
Several guidelines for the comet assay have been published 27-31. However, no 
standardised protocol exists as yet and there are considerable differences in the 
protocols used by different research groups, which negatively affect inter-laboratory 
comparisons of results. Although the inter-laboratory variability is well-known, few 
studies have addressed this issue. Several experts on the field have highlighted the need 
for multi-laboratory international validation studies to assess intra- and inter-laboratory 
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The papers in this thesis can be divided into two parts; one part that deals with 
international inter-laboratory validation studies and methodological aspects of the 
comet assay (paper I-III) and the other part covering a human intervention study with 
antioxidant capsules consisting of many different antioxidants in low doses for which 
the comet assay has been applied (paper IV-V). 
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2 RESEARCH AIMS  
The general aims of this thesis were to present and investigate the possibilities and 
limitation of the comet assay, and to investigate whether the level of oxidative stress 
could be decreased by supplementation of a mixture consisting of a range of 




a) To investigate inter-laboratory variations in DNA breaks and Fpg-sensitive 
sites measured by the comet assay (papers I and II).  
b) To assess the possibility of reducing the variation between laboratories 
through calibration with reference samples (papers I and II). 
c) To assess the variability in scoring and staining by analysis of slides prepared 
by one laboratory (paper I). 
d) To investigate the impact on DNA migration by different comet assay 
protocols (papers II and III). 
e) To assess the possibility of reducing the variation between different protocols 
through calibration with reference samples (paper III). 
f) To examine the possibility of modifying the level of oxidative stress in 
healthy, middle-aged, over-weight males by supplementation with a mixture 
of antioxidants in low doses (paper IV). 
g) To examine the ability of α- and γ-tocopherol to protect against oxidative 
DNA lesions (paper V). 
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3 THE ANALYTICAL METHOD COMET ASSAY 
The focus throughout this thesis is on the alkaline (pH>13) comet assay and Fpg comet 
assay since these applications have been used in the constituent papers. The alkaline 
(pH>13) comet assay, and utilisation of enzymes for assessment of specific lesions, are 
described in section 3.2. In addition, a number of other applications of the comet assay 
will be briefly described, including assessment of a) DNA damage in specific genes in 
combination with the FISH methodology (section 3.3), b) DNA-DNA cross-links 
(section 3.4), and c) DNA incision activity reflecting BER and NER (section 3.5). From 
now and onwards, the alkaline comet assay (pH>13) will be referred to as the alkaline 
comet assay, whereas the alkaline comet assay combined with enzyme treatment are 
referred to as the Fpg comet assay, the EndoIII comet assay etc, depending on the 
enzyme. 
 
3.1 A BACKGROUND TO THE DIFFERENT VERSIONS OF THE COMET 
ASSAY 
The principles of the comet assay was first introduced in 1984 by Östling & Johanson 
32. This original protocol is often referred to as neutral although a pH of 9.5 was 
employed. Although this value is far above what is normally referred to as neutral pH 
(pH 7), it is nonetheless insufficient to unwind DNA. A few years later, Singh et al. 
described the alkaline comet assay, including lysis in a buffer with high salt 
concentration and a subsequent 20 min of alkaline treatment in a strong alkaline 
solution (pH>13), followed by 20 min of electrophoresis in the same solution 33. In 
1989, Olive et al. introduced a version of the comet assay where slides were submerged 
in a neutral solution consisting of Tris/EDTA buffer before electrophoresis 34. In 1990, 
Olive et al. introduced yet another version of the comet assay using a weak alkali 
solution (pH∼12.3) 35. Today, the alkaline (pH>13) version of the assay, which detects 
DNA strand breaks and ALS, is most frequently used and is considered the optimal 
version for identification of genotoxic agents 31. Several guidelines for the comet assay 
have been published 27-31, but there is no standardised protocol and there are 
considerable differences in protocols used by various research groups. Many, but not 
all, protocols are covered by the general procedure described in the following section. 
The specific protocol that is currently used by the author of this thesis is described in 
detail in paper III.  
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3.2 THE GENERAL PROCEDURE OF THE ALKALINE AND ENZYME 
COMET ASSAYS 
In short, cells are embedded in agarose and lysed at pH 10, leaving a structure called a 
nucleoid. To specifically measure oxidatively damaged DNA (or some other types of 
DNA lesions described in section 3.2.4), an additional step of digestion with DNA 
glycosylase can be added. The glycosylase recognises and removes lesions leaving an 
abasic site, which is converted to a strand break either by the enzyme’s attached lyase 
activity or by the subsequent alkaline treatment. To obtain single stranded DNA, 
treatment with an alkali solution is performed. Following this, electrophoresis is done 
under the same alkaline conditions as the previous step, where the strand breaks 
through their ability to relax DNA supercoiling, allow the negatively charged DNA 
loops to extend towards the positively charged anode. The DNA is stained and a tail 
(comet) of mainly single stranded DNA can be seen with a fluorescence microscope 




Figure 2. Comets scored with a fluorescence microscope. Photo by Staffan Larsson. 
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The comets are analysed either by using visual scoring or computerised image analysis. 
The magnitude of the DNA-tail provides information about the level of DNA lesions. A 
schematic description of the assay is depicted in figure 3. In the following sections, the 
general procedure of the comet assay is described step by step.  
 
Figure 3. Schematic description of the different steps in the comet assay.  
 
 
3.2.1 Cell suspension 
The comet assay can be applied to basically any cells with nuclear DNA where a single 
cell suspension can be obtained. Cells from tissue biopsies that can be homogenised, 
buccal cells obtained by scraping of the buccal cavity, cells isolated from blood, whole 
blood, cultured cells, and even plant cells can be used, although some cell types, such 
as plant cells and sperm cells, require modified protocols. It is more frequent to isolate 
PBMC than to perform comet assay on whole blood. The PBMC can be analysed 
directly after isolation or be frozen down under appropriate conditions, which allows 
multiple analyses or simultaneous analysis of different samples, such as those collected 
before and after exposure. PBMC are isolated from blood by density gradient 
centrifugation using commercially available tubes/solutions like Lymphoprep™, 
Histopaque™-1077 or BD Vacutainer® CPT™. Whole blood, on the other hand, does 
not require centrifugation. It has recently been suggested that whole blood, frozen in 
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holds true following rigorous evaluation, it would not only save time for those who are 
working with the comet assay, but also allow for comet assay analysis of samples 
archived in biobanks 36.  
 
3.2.2 Agarose 
Cells in suspension are mixed with low melting point (LMP) agarose and the mixture is 
allowed to solidify to a gel on a microscope slide, already pre-coated with agarose, or 
on a GelBond® film. When it comes to glass slides, clear ones are recommended as 
opposed to the fully frosted slides frequently used in the past, as the latter suffers from 
a high background noise 28. Normally, one electrophoresis slide contains 1-3 agarose 
gels, each gel containing a few thousand cells. Recently, however, Shaposhnikov et al. 
showed how using 12 agarose mini-gels per slide substantially increased the amount of 
samples that can be analysed in a single experiment 37.  
 
3.2.3 Lysis 
The slides (or GelBond® films) are placed in a lysis solution for a minimum of 1 h at 4 
°C. During lysis, membranes, cytoplasmic and nuclear constituents and most histones 
are removed. The structure remaining after lysis is called a nucleoid and consists of 
supercoiled DNA attached to a nuclear matrix. The lysis buffer frequently consist of 2.5 
M NaCl, 0.1 M EDTA, 10 mM Tris, pH 10 and 1% Triton X-100, but some researchers 
also add dimethyl sulfoxide (DMSO) and/or N-lauroylsarcosine. Triton X-100 is 
generally sufficient for cell lysis, although a second detergent might be necessary for 
complete lysis for some cell types 31. Triton X-100, which act as a detergent, is added at 
the day of the experiment by gentle stirring, preferably for at least 1 h based on 
observations by the author of this thesis (but at a minimum for 15 min 38). Hartmann et 
al. stated in 2003 that N-lauroylsarcosine was considered redundant 29.  
 
3.2.4 Enzyme treatment  
DNA glycosylases can be added to the alkaline comet assay to measure specific DNA 
lesions. DNA glycosylases that have been used in the comet assay include Fpg 10, 
EndoIII 11, hOgg1 12, AlkA 13, T4 endonuclease V 14, 15 and UNG 16. DNA glycosylases 
travel (slide) along the DNA chain and when it faces a damaged base, a structural 
change take place where the damaged base is partitioned forward to the active site of 
the enzyme where the glycosidic bond between the damaged base and the sugar is 
cleaved 39. The resulting abasic site leads to a strand break either by the enzyme’s 
associated lyase activity or by the subsequent alkaline treatment. Glycosylases are 
either monofunctional, i.e. they remove the damaged base by cutting the glycosidic 
bond between the base and the sugar, or bifunctional, i.e., in addition to removing the 
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damaged base by cutting the glycosidic bond, it also cut the DNA backbone 40. 
Incubation of slides with only buffer or buffer containing enzyme enables an estimation 
of both DNA breaks and the calculation of net enzyme-sensitive sites. The enzyme 
most frequently used in the comet assay, Fpg, recognises and removes mainly 8-
oxoguanine but also a range of other lesions. The substrates of the glycosylases that 
have been used in the comet assay are listed below (incomplete list). However, it 
should be emphasised that establishing substrates in vitro does not necessarily mean 
that the enzymes recognise all of these substrates in vivo. Some of the most common 




Figure 4. The DNA bases and some of the most common products of base oxidation. 
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Fpg  
Fpg recognises and removes primarily oxidised purines such as 8-oxoguanine (which is 
the main substrate) and the formamidopyrimidines 2,6-diamino-4-hydroxy-5-
formamidopyrimidine (fapy-guanine) and 4,6-diamino-5-formamidopyrimidine (fapy-
adenine) (figure 4) 41, 42. Fpg has also been reported to recognise a range of other 
lesions, e.g. 5-hydroxycytosine, thymine glycol, abasic sites, 8-oxoadenine, various 
kinds of ring opened 7’-nitrogen and 8’-carbon guanine adducts and alkylation damage 
(probably alkylation of the 7’-nitrogen of guanine) 41-44. 8-oxoguanine can also be 
further oxidised into spiroiminodihydantoin and 5-guanidinohydantoin, which have 
also been shown to be recognised by Fpg 45. In addition to the glycosylase activity, Fpg 
has associated lyase and endonuclease activities (see section 6.4.1) 42, 43, 46.  
 
EndoIII  
EndoIII recognises pyrimidine oxidation products and its main substrate is thymine 
glycol (figure 4). It also recognises a wide variety of other substrates including abasic 
sites, urea, uracil glycol, 5,6-dihydrothymine, 5-hydroxy-6-hydrothymine, 5-
hydroxyuracil, 5,6-dihydrouracil, 5-hydroxy-6-hydrouracil and 5-hydroxycytosine 43, 47. 
EndoIII has an associated lyase activity 43, 47.  
 
hOgg1  
hOgg1’s main substrate is 8-oxoguanine, which it is considered to detect with a higher 
specificity than Fpg 12, although it also recognises other lesions, including abasic sites 
opposite cytosine, methyl-fapy-guanine paired with cytosine and 7-methyl-8-
oxoguanine 46, 48. hOgg1 has an associated lyase activity 49, although it appears to be 
less efficient than that of Fpg 43.  
 
AlkA 
AlkA’s main substrate is 3-methyladenine but it is a very promiscuous non-specific 
enzyme 43, 50. AlkA recognises a range of alkylated bases including 3’-nitrogen and 7’-
nitrogen adducts of adenine and guanine, respectively, and alkylation damage of 
cytosin’s exocyclic oxygen 43, 50. AlkA has even been shown to attack undamaged 
DNA at high concentrations 50. AlkA has no associated lyase activity 43. 
 
T4 endonuclease V 
Endonuclease V from T4 phage is a glycosylase/lyase, which has a narrow substrate 
specificity for UV-induced cyclobutane pyrimidine dimers, of which the cis-syn T-T 
dimer is the preferred substrate 43.  
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UNG  
Uracil in DNA, originating from deamination of cytosine or from misincorporation into 
DNA 51, is recognised and excised by UNG. The glycosylase removes uracil in both 
double-stranded and single-stranded DNA with high specificity but has also been 
reported to recognise other lesions, such as 5-fluorouracil, 5-hydroxyuracil, isodialuric 
acid and alloxan 43, 47, 51. UNG has no associated lyase activity 43, 47. 
 
Other enzymes 
A study assessing whether the comet assay can be modified to assess epigenetic 
changes using enzymes is ongoing (Nagy et al., in preparation). Attempts have been 
made to use the enzyme complex uvrABC in the comet assay, but the enzyme failed to 
find sufficient levels of its substrate 10, 52.   
 
3.2.5 Alkaline treatment 
In order to unwind and denature DNA, and hydrolyse ALS, the slides are placed in an 
alkaline solution (0.3 M NaOH, 1 mM EDTA, pH > 13) for typically 20-40 min at 4°C. 
This is performed directly after lysis in the alkaline comet assay, or after enzyme 
treatment in the enzyme version of the comet assay. 
 
3.2.6 Electrophoresis 
Following alkaline treatment, electrophoresis is performed under alkaline conditions 
where the strand breaks by their ability to relax DNA supercoiling of DNA loops allow 
DNA to extend out from the nucleoid under the influence of an electric field 53. 
Electrophoresis is typically performed for 20-30 min, often at 0.8-1.2 V/cm. The 
negatively charged DNA migrates towards the positively charged anode, creating an 
image that resembles a comet. In the lab of the author of this thesis, a black COMET-
20 tank (Scie-Plas Ltd, Cambridge, UK) is used, which has ice-cold water circulating 
under the platform to keep the buffer in the tank at a constant temperature. It also aids 
in blocking light from reaching the gels as better results are obtained when this step is 
performed in darkness. 
 
3.2.7 Neutralisation 
DNA is neutralised, for example by placing the slides in phosphate buffered saline 
(PBS) or 0.4 M Tris, pH 7.4. 
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3.2.8 Fixation 




The DNA is stained by a DNA binding fluorescing dye, e.g. ethidium bromide (EtBr), 
propidium iodide (PI), 4’,6-diamidino-2-phenylindole (DAPI), SYBR Green, SYBR 
Gold, YOYO®-1 iodide ´(YOYO-1), or by a non-fluorescing dye, i.e. silver nitrate.  
 
3.2.10 Scoring of comets 
A comet with a head of mainly supercoiled DNA and a tail of extended DNA loops and 
DNA fragments can be seen with a fluorescence microscope 53. The comets are 
normally analysed with UV-fluorescence microscopy. The comets can be analysed by 
visual scoring, by computerised image analysis or by the recently developed automatic 
computerised analysis (discussed in section 5.1.6) 54. There is a range of different 
software available to analyse comets, for example Comet Assay IV™ (Perceptive 
Instruments, Suffolk, UK) and Komet (Kinetic Imaging Ltd, Bromborough, UK).  
 
3.2.11 Different endpoints 
Visual scoring is reported as arbitrary units (a.u.), often in a scale 0-400. The comets 
are divided into five classes ranging from undamaged to very damaged cells as 
described by Collins et al. 11. Computerised scoring is reported using a range of 
different endpoints. The most frequently used endpoints for computerised scoring are 
probably %DNA in tail, tail moment and tail length. In addition, different distributions 
of comet images are sometimes described. These units are discussed in chapter 5. 
Calibration with ionising radiation, i.e. γ-rays or X-rays, allows for primary comet 
assay endpoints to be reported in ‘real’ damage levels such as lesions/106 base pair 
(bp), which is described and discussed in sections 5.3.1 and 5.3.2. 
 
3.3 FISH COMET ASSAY 
The FISH application of the comet assay is technically demanding, but can provide 
unique information about the DNA damage and repair in specific genes and DNA 
sequences 22. By hybridising fluorescently labelled probes to DNA after 
electrophoresis, DNA damage and repair in particular genes and DNA sequences can 
be measured by the comet assay 22, 55, 56. If the DNA of the gene is found in the comet 
tail, this indicates that a DNA break has occurred in the proximity of the gene 55.  
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3.4 DETECTION OF CROSS-LINKS  
A modified version of the comet assay can be used to measure DNA cross-links 21, 57. 
This type of lesion can be highly toxic to the cell, as it can result in inhibition of DNA 
strand separation during replication and transcription 21. In this assay, a known amount 
of strand breaks are induced in cells by radiation. When performing the comet assay, 
the cross-links’ potential to inhibit DNA migration results in a decreased DNA 
migration proportional to the level of inter-strand cross-links 21.  
 
DNA cross-links reduce the migrating capability of DNA, which can result in 
misinterpretation of results obtained by the regular alkaline comet assay. If suspecting 
that cells contain DNA-protein cross-links, an additional step can be added where the 
lysed cells are exposed to proteinase K before alkaline treatment in the alkaline comet 
assay 31. 
 
3.5 THE IN VITRO COMET REPAIR ASSAY 
In short, to measure DNA incision as an estimate of DNA repair capacity, a cell extract 
containing DNA repair enzymes is obtained from cells (frequently lymphocytes), by 
lysis of the membranes and addition of a buffer. Cells with induced DNA damage are 
embedded in agarose on a microscope slide, and lysed to expose the DNA, followed by 
incubation with the cell free lymphocyte extract containing DNA repair enzymes. The 
extract’s incision activity (the first step in the repair process) on DNA damage is 
measured by the comet assay. Depending on the character of the induced DNA 
damage, BER and NER can be measured. To measure BER by Ogg1, 8-oxoguanine is 
induced by exposing cells to visible light when mixed with Ro 17. To measure NER of 
bulky DNA adducts, damage is induced by benzo[a]pyrene-diol-epoxide 18. To measure 
NER of UV-induced damage (mainly cyclobutane pyrimidine dimers and pyrimidine 6-
4 photoproducts), damage is induced by UVC 19. To measure NER repair of DNA 
cross-links, damage can be induced by oxaliplatin 20. 
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4 VALIDATION OF THE COMET ASSAY  
To be able to use biomarkers as tools in cancer risk assessment, the biomarkers must be 
extensively validated. Validation of the comet assay is crucial for its value as a tool to 
identify and monitor a) environmental and occupational hazards, b) diseases linked 
with oxidative stress, c) the effects of nutrition, d) the effect of medical treatments, and 
e) to assess individual susceptibility 58. The validation process is continuous and 
important steps include the evaluation of exposure-effect relationships in laboratory 
studies and in biomonitoring studies on humans, and demonstrating associations 
between the biomarkers and disease 59. An important step of biomarker validation is 
inter-laboratory validation studies. Several experts in the field have emphasised that in 
order to demonstrate the comet assay’s inter- and intra-laboratory reproducibility, 
reliability, and to investigate sources of variability in results, the method needs to 
undergo multi-laboratory, international validation studies 8, 29, 31. The European 
Standards Committee on Oxidative DNA damage (ESCODD) and European Comet 
assay Validation Group (ECVAG) networks have assessed several aspects of the 
validation of the comet assay. Prof. Lennart Möller’s research group has been a 
member of both ESCODD and ECVAG, established in 1997 and 2006, respectively. 
The first two studies performed by the ECVAG network are included in this thesis 
(papers I and II). The author of this thesis is involved in four additional (ongoing) 
ECVAG studies. The objectives of all the ECVAG studies are described in section 4.2. 
The findings of these studies are discussed in this and the following chapter. Some of 
the most important aspects assessed by the ECVAG network are a) precision (variation 
between laboratories), b) reproducibility (repeated analysis of identical samples), and c) 
sensitivity (the ability to measure dose-responses). 
 
4.1 THE WORK OF ESCODD  
ESCODD was established in 1997 after scientists had observed that different methods 
used to analyse the level of oxidative DNA lesions, i.e. 8-oxoguanine, gave different 
results 60. Scientists using gas chromatography-mass spectrometry (GC-MS) techniques 
reported values that were about 10 times higher than those obtained using high 
performance liquid chromatography with electrochemical detection (HPLC-EC). Even 
lower levels of 8-oxoguanine were seen with enzymatic methods, e.g. the comet assay 
60. Collaborations through ESCODD were set up in order to examine differences 
between the methods, validate them, develop trustworthy techniques, and to reach a 
consensus about the true background level of 8-oxoguanine. ESCODD consisted of 27, 
mainly European, laboratories, which performed several inter-laboratory validation 
studies. Samples of 8-oxo-7,8-dihydro-2’-deoxyguanosine (8-oxodG), oligonucleotides 
  16 
containing 8-oxodG, calf thymus DNA and pig liver 61, 8-oxodG, untreated calf thymus 
DNA and calf thymus DNA with experimentally induced 8-oxoguanine 62, 
oligonucleotides containing different amounts of 8-oxodG but without undamaged 
guanine 63, 8-oxodG, 2’-deoxyguanosine (dG), untreated calf thymus DNA and calf 
thymus DNA with experimentally induced 8-oxoguanine 64, pig liver and untreated 
human transformed epithelial (HeLa) cells 65, undamaged HeLa cells and HeLa with 
experimentally induced 8-oxoguanine 66, and, lymphocytes from healthy men and 
untreated HeLa cells 67 have been analysed using different methods by the members of 
ESCODD. As the comet assay requires intact cells for analysis, this methodology was 
introduced only at a later stage into the ESCODD validation project 65-67, since the first 
studies were performed on DNA constituents. ESCODD reported that the enzymatic 
methods were less susceptible to artefact oxidation, and hence, reported variations in 
background levels were lower compared to HPLC-EC methods, although, the latter 
method was better at detecting a dose-response 66. However, both the background 
levels and the dose-range were much lower for the comet assay (HeLa cells were 
exposed to 0-0.4 µM Ro for 2 min for the comet assay and 0-5 µM Ro for 5 min for the 
chromatographic methods), which precludes a direct comparison 66. Seven out of eight 
laboratories reported very similar dose-response slopes when analysing HeLa cells 
containing 8-oxoguanine in their DNA with HPLC-EC methods, although the 
background levels (the intercept) varied substantially 66. In comparison, only three out 
of eight laboratories could detect the dose-response relationship in net Fpg-sensitive 
sites using the comet assay 66. Gedik et al. had previously showed that the slopes of the 
dose-response curves obtained by the HPLC-EC method and the comet assay, when 
analysing cells containing 8-oxoguanine in their DNA, were similar 68. However, as in 
the ESCODD study, the background level, as well as the dose range, was substantially 
lower for the comet assay than for the HPLC-EC method 68. The ESCODD network 
estimated the normal background level of 8-oxoguanine in human lymphocytes to be 
between 0.3 and 4.2 8-oxoguanines per million undamaged guanine bases 67. 
 
4.2 THE WORK OF ECVAG 
ECVAG was created within the Environmental Cancer Risk, Nutrition and Individual 
Susceptibility (ECNIS) network of excellence in 2006, and currently consists of 14 
laboratories that perform validation studies of the comet assay. Each of these studies 
will result in a scientific paper. The author of this thesis is a co-author of six of these 
papers (studies 1-3 and 5-7 below), of which two have been published and are included 
in this thesis (papers I and II). Of the remaining ongoing studies, two studies have 
recently terminated and the manuscripts are now under preparation (studies 3 and 5). 
For studies 6 and 7, we have not yet received results from all participating laboratories 
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and all obtained results are still coded. In this section, the objectives of the seven 
ECVAG studies are described briefly.  
 
Study 1 (paper I in this thesis) comprised of inter-laboratory investigations of three key 
areas; a) variation in scoring of pre-made slides to assess the influence of scoring and 
staining, b) inter-laboratory variation in analysing DNA breaks in coded samples to 
assess the inter-laboratory variation, and c) the possibility to reduce the inter-laboratory 
variation by using protocol-specific calibration curves 69. The first part of this study 
included scoring of pre-made slides containing nucleoids with varying degrees of DNA 
migration. In the second part of this study, frozen human acute monocytic leukaemia 
THP-1 cells containing DNA breaks (for calibration curve samples and coded samples, 
respectively) were distributed to 12 participating laboratories that were to analyse these 
samples using their own comet assay protocols.  
 
Study 2 (paper II in this thesis) aimed to investigate a) the participating laboratories’ 
abilities to detect a dose-response in coded samples containing 8-oxoguanine, b) the 
inter-laboratory variation in reported Fpg-sensitive sites in coded samples, and c) the 
possibility to reduce the inter-laboratory variation by using protocol-specific calibration 
curves 70. Reference cells containing DNA breaks, and coded cells containing 
oxidatively damaged DNA, were distributed to 10 participating laboratories, that were 
instructed to analyse these samples using their own comet assay protocols. 
 
Study 3 involved eight laboratories’ abilities to detect DNA repair capacity as incisions 
per 106 bp in three different cell lines using the in vitro comet repair assay (Godschalk 
et al., in preparation).  
 
Study 4. The ability to reduce intra-experiment and inter-experiment variability in 
DNA migration by using an authentic internal standard was assessed by Zainol et al. 71. 
In this study, Zainol et al. introduced a true internal standard for the comet assay, by 
embedding distinguishable ‘reference’ cells in the same gel as the test comets that were 
to be investigated (see section 5.3.3). 
 
Study 5. In this study, the ability to decrease the inter-laboratory variation by adopting 
a set of reference conditions was assessed (Forchhammer et al., in preparation). In the 
reference protocol, the protocol parameters that were considered to be the most 
important were fixed, i.e. the a) agarose concentration (1% final concentration), b) 
duration of enzymatic incubation (30 min), c) time of alkaline treatment (20 min), d) 
strength of the electric field (1.2 V/cm), and e) duration of electrophoresis (20 min). 
The reference conditions also included the composition of the solutions/buffers used, as 
well as the dilution of the enzyme. Moreover, the participants were instructed to change 
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their image analysis system settings if they deviated from distributed pictures. The 
participating 14 laboratories analysed coded reference samples and PBMC, both with 
their own protocols and the reference protocol.  
 
Study 6 is still ongoing. In this study, the intra- and inter-laboratory variation in 
detected DNA damage in PBMC will be assessed. By analysing three identical coded 
samples of PBMC from three different donors and standard curve samples on three 
different days, using the participants’ own protocols, the intra-day, the day-to-day, and 
the inter-laboratory variation in DNA breaks and Fpg-sensitive sites can be assessed.  
 
Study 7. In this ongoing study, the inter-laboratory variation in detecting DNA damage 
in PBMC will be assessed. The participating laboratories have received coded samples 
containing PBMC collected in five different countries using the same technique, and 
have been instructed to analyse these with their own protocols. 
 
4.3 DOSE-RESPONSE RELATIONSHIPS IN THE ECVAG STUDIES 
In general, the participants in the ECVAG studies (papers I and II) could detect dose-
responses in both reference cells and coded samples. However, there was a large inter-
laboratory variation in the reported primary comet assay endpoints, i.e. in the reported 
a.u. and %DNA in tail. This variation was attributed to both differences in comet assay 
protocols and image analysis. The dose-response relationships in papers I and II are 
presented shortly in this section, whereas influences of protocol and image analysis are 
mainly discussed in the next chapter. 
 
4.3.1 Analysis of calibration curve samples 
In both paper I and paper II, calibration curve samples irradiated with 0, 2.5, 5 and 10 
Gray (Gy) of γ-radiation were distributed to the participating laboratories to be analysed 
with the participants’ own protocols. In paper I, the dose-dependent relationships for 
the calibration curves (R2median = 0.987, range: 0.895-0.992) were significant for 11 
laboratories (P < 0.05) and borderline significant (P = 0.054) for one laboratory 
(ANOVA). In paper II, all 10 participating laboratories reported significant dose-
dependent relationships in the calibration curves (R2median
 = 0.970, range: 0.931-0.995, 
P < 0.05, ANOVA). Calibration curves are discussed in section 5.3.1. 
 
In paper I, an assessment of the contribution of the intra- and inter-laboratory variation 
to the overall variation was made by comparing the standard curves from the three first 
ECVAG studies (papers I and II, and ECVAG study 3 [Godschalk et al., in 
preparation]) 69. The contribution to the overall variation was to a large extent from 
  19 
radiation (66%) followed by inter-laboratory variation (21.6%; P < 0.001 for both 
variables) 69. In addition, the unexplained contribution of 12.3% to the overall variation, 
was much larger than the intra-laboratory variation, which was only 0.1% 69. However, 
the study design of paper I does not allow discrimination between day-to-day and intra-
laboratory variation. These two variables will, however, be assessed in ECVAG study 6 
by using a Latin square design (analysis of three donors and three identical samples per 
donor on three different days).  
 
4.3.2 Analysis of coded pre-made slides and cryo-preserved coded cells 
containing DNA breaks 
In paper I, all participating laboratories detected the same ranking in the coded pre-
made slides, which consisted of gel-bonds containing embedded cells exposed to 0, 2.5, 
5 and 10 Gy of γ-radiation and subject to a fixed comet assay protocol at the University 
of Copenhagen (figure 5). Figure 5 in this thesis deviate slightly from figure 1b in paper 
I, since all laboratories (n = 12) have been included in the figure in this thesis. The 
largest standard deviation was seen for the highest dose of γ-radiation, with DNA 
migration ranging from 29.0 to 94.6 %DNA in tail or a.u. in the scale 0-100. The inter-
laboratory variation in the pre-made slides was surprisingly high, which indicated that 
the image analysis, perhaps together with staining of cells, is an important parameter 
affecting the outcome of the comet assay. Since the pre-made slides consisted of the 
same cells as the coded cryo-preserved samples, an attempt to assess the contribution of 
the image analysis could be made by a statistical model (where the level of DNA 
damage in the coded samples was the dependent variable, the laboratory categorical 
variable, and the dose of γ-radiation and the DNA damage in the pre-made slides 
continuous variables). All factors significantly predicted the level of DNA migration: 
dose of γ-radiation (P < 0.001), laboratory (P < 0.001), and the reported levels of DNA 
migration in the pre-made slides (P < 0.01), which indicated that even though the dose 
of γ-radiation was the strongest predictor, both image analysis and comet assay protocol 
significantly affected the outcome of the comet assay 69. The impact of protocols and 
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Figure 5. DNA breaks in the pre-made slides (%DNA in tail for n = 11 and a.u. in the 
scale 0-100 for n = 1). Each line represents the value from one laboratory. 
 
 
In paper I, all participating laboratories detected the same ranking in coded THP-1 cells 
irradiated with 1.5, 2.5, 5 and 7 Gy of γ-radiation analysed using respective protocols. 
Both the dose of γ-radiation and the inter-laboratory variation contributed highly 
significantly (P < 0.001, n = 12) to the variation in primary comet assay endpoints 
(with 43.6% and 43.5% of the total variation, respectively). We showed in paper I that 
the inter-laboratory coefficient of variation (CV) could be significantly decreased from 
47% to 28% by transforming the primary comet assay endpoints to lesions/106 bp by 
using protocol-specific calibration curves as compared to a common calibration curve 
(Levene’s test) 69. Adjusting primary comet assay endpoints to the own calibration 
curves reduced the inter-laboratory variation from 43.5% to 16.3% of the total variation 
and increased the contribution of the dose of γ-radiation from 43.6% to 77.1% 69. 
Transformation of primary comet assay endpoint into real units by using calibration 
curves is further discussed in the following chapter. 
 
Coding is recommended to avoid scoring bias. In paper I, the dose of γ-radiation 
contributed less to the overall variation in the coded samples than in the calibration 
curve samples, which was not coded 69. However, there was no statistically significant 
difference between the reference samples and coded samples exposed to the same doses 
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4.3.3 Analysis of coded samples containing oxidatively damaged DNA 
In paper II, nine out of ten participating laboratories detected the same positive ranking 
of the sum of DNA breaks and Fpg-sensitive sites in the coded A549 human type II 
alveolar epithelial cells exposed to 0, 0.2 and 0.8 µM Ro and light, once again analysed 
using respective protocols. Similarly, seven out of eight participating laboratories 
detected the dose-response when calculating the net Fpg-sensitive sites (figure 6). The 
used comet assay protocols significantly affected the outcome of the comet assay 
(discussed in the following chapter). After conversion of the primary comet assay 
endpoints to lesions/106 bp, by using the laboratory-specific calibration curves, the 
contribution of the dose of Ro increased from 49% to 73% of the total variation, 
whereas the inter-laboratory variation decreased (figures 6a and 6b). 
 
 
Figure 6. The level of net Fpg-sensitive sites in coded samples with A549 cells 
exposed to 0, 0.2 or 0.8 µM Ro and light. Eight laboratories used their own comet assay 
protocols to measure the net Fpg-sensitive sites. Data are presented as (A) %DNA in 
tail (n = 7) and a.u. in the scale 0-100 (n = 1), and as (B) lesions/106 bp. The fraction of 
explained variation strongly increased when using lesions/106 bp as endpoint. The 
amount of lesions/106 bp was calculated based on the assumption that 1 Gy induces 
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4.4 THE ECVAG DOSE-RESPONSE, AN IMPROVEMENT SINCE 
ESCODD.  
Regarding net Fpg-sensitive sites, seven out of eight laboratories identified this dose-
response in paper II 70. In a similar trial conducted by ESCODD published in 2003, 
only three out of eight laboratories could detect the dose-response relationship in net 
Fpg-sensitive sites using the comet assay 66. In addition, two laboratories that used 
other enzymatic methods (alkaline elution and alkaline unwinding, respectively), also 
detected the dose-response 66. In the ESCODD trial, HeLa cells were exposed to 0, 0.2 
or 0.4 µM Ro and light for 2 min 66, whereas A549 cells were exposed to 0, 0.2 or 0.8 
µM Ro and light for 5 min in paper II 70. The wider concentration range used in the 
ECVAG trial might explain why we were more successful at detecting the dose-
response than ESCODD.  
 
In conclusion, the participants in ECVAG were successful in detecting dose-responses 
in coded samples 69. However, although comet assay is a valuable and reliable tool to 
detect DNA damage in biological samples, there was considerable inter-laboratory 
variation due to differences in protocols and in image analysis. This is extensively 
discussed in the following chapter. 
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5 CONCERNS AND SOLUTIONS RELATED TO THE 
COMET ASSAY  
A major concern with the comet assay is that there is no standardised protocol, and 
results depend to a large extent on the protocol that is used. Several guidelines for the 
comet assay have been published 27-29, 31, but no standardised protocol exists and there 
are considerable differences in those used by different research groups. These 
differences negatively impact the inter-laboratory comparisons of results. The results in 
paper I indicated that both protocol and image analysis affected the outcome of the 
comet assay, but no individual protocol parameters could be identified as particularly 
important 69. The results in paper II, however, pointed to several important aspects in 
the procedures that may affect DNA migration 70. It shall be emphasised that neither 
paper I, nor paper II, was designed to investigate differences in protocols as they 
involved too few observations with large procedural variability, which resulted in very 
poor statistical power. Based on the results in paper II, we decided to assess the impact 
of some particularly important parameters in the comet assay procedure and compile 
them in a methodology paper (paper III). The results from this initiative verified that 
the protocols clearly affect the level of DNA migration in the comet assay 72. It 
wouldn’t have been feasible to test all protocol variables, hence a subset was chosen, 
which were likely to have a large impact on the endpoint. The influence of the protocol 
is thoroughly discussed in the first section of this chapter. Parameters that have not 
been investigated in papers II or III have been observed or suggested to affect the DNA 
migration by others 73. In addition, several other concerns and solutions related to the 
comet assay are discussed, such as the use of different units, application of reference 
standards and standardised protocols, range of detection of the method, enzyme 
specificity, and problems that need to be overcome in order to transform the comet 
assay to a high-throughput assay that can be used in large biomonitoring studies. In the 
last section of this chapter, possible interactions of particles with the enzyme Fpg are 
mentioned. Frequently, comet assay is said to measure DNA breaks, enzyme-sensitive 
sites etc, which is in a strict definition imprecise, since it is DNA migration that is 
measured as an estimate of different types of DNA lesions and repair. Therefore, when 
reporting and discussing the influence of protocol on the outcome of analysis (in this 
chapter and in paper III), the expression “DNA migration” was considered to be the 
most appropriate term to use. 
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5.1 THE CHOSEN COMET ASSAY PROTOCOL AFFECTS THE LEVEL 
OF DNA MIGRATION 
Many parameters in the comet assay protocols used by different investigators differ 
substantially; for example, the density of the agarose gels, duration of the alkaline 
unwinding and electrophoresis, and strength of the electric field used. It was not within 
the objectives of paper II to identify what elements in the different comet assay 
protocols were of importance for DNA migration. The aim was simply to assess 
variation in estimates of oxidatively damaged DNA between different laboratories 
using their respective Fpg comet assay procedures. Observations suggested, however, 
that some protocol steps were of particular importance, i.e., agarose density, duration of 
enzyme treatment, extent of alkaline treatment, and time of electrophoresis, and thus 
we decided that it was of interest to report this, although, as emphasised in paper II, the 
design of the study was not optimal for such statistical evaluations. The aim in paper III 
was to assess the protocol parameters that seemed to affect the outcome in paper II in 
detail. Paper III, confirmed that a) there is a significant linear dose-response 
relationship between the agarose gel density and DNA migration, and that damaged 
cells are more sensitive to density variation, b) incubation with Fpg for 10 min is 
inadequate, whereas 30 min is sufficient, c) the typically used 20 min of alkaline 
treatment might be too short when analysing samples that contain particular ALS, and 
d) the duration of electrophoresis, as well as the strength of the electric field applied, 
affect the DNA migration 72. The study design of paper III, with respect to the above 
mentioned parameters, were to a large extent based on the protocols used by the co-
authors of papers I and II 69. Also, the protocol used in the laboratory of the author of 
this thesis was always included. In the following section, the different parameters of the 
comet assay protocol are discussed with focus on those studied in papers II and III. 
 
5.1.1 Agarose concentration 
In paper II, multiple regression analyses of the influence of protocol parameters on 
oxidative DNA lesions indicated that the agarose density significantly contributed to 
the variation in DNA migration when different laboratories analysed coded samples 
with induced oxidative DNA lesions 70. The agarose density was significantly 
correlated to the DNA migration for both the sum of strand breaks and Fpg-sensitive 
sites (P < 0.001, negative association), and the net Fpg-sensitive sites (P < 0.05, 
negative association) in a multiple regression analysis (where the level of DNA lesions 
expressed as %DNA in tail was the dependent variable, whereas the concentration of 
Ro, agarose density, duration of alkaline treatment, enzyme treatment and 
electrophoresis were covariate [continuous] variables) 70. However, the ECVAG study 
was not designed to investigate contribution of protocols, and when the contribution of 
the agarose was analysed in a model solely with the concentration of Ro, it did not 
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significantly affect the variation in Fpg-sensitive sites 70. Although it may seem trivial 
to delve into agarose concentration and DNA migration, no thorough investigation of 
the impact of this parameter in the alkaline comet assay protocols had been performed 
(published) as far as we were aware at that time. Several articles had referred to Tice 23, 
stating that agarose concentration affects the outcome, but no data was presented. We 
showed in paper III (figure 7) that there is a significant linear dose-response between 
the agarose gel density and DNA migration, which is in accordance with recent 
findings by Azqueta et al. 72, 74. A similar pattern was observed by Bauch et al., who 
observed that by increasing the agarose concentration from 0.5 to 1% and from 0.5 to 
1.5%, the %DNA in tail was reduced by a factor of 2 and 3, respectively, using a 
neutral comet assay protocol 75. In paper III, cells exposed to 5 Gy of γ-radiation 
seemed to be more sensitive to alterations in agarose density than untreated cells (figure 
7), indicating that the sensitivity of the comet assay can be modified by altering agarose 
concentration 72. However, Azqueta et al. recently concluded that a final agarose 
concentration between 0.6 and 0.8% seems to be optimal to avoid unstable gels and 
impeded DNA migration 74. Even though Bauch et al. used a different comet assay 
protocol than the one employed in the papers in this thesis, they came to the conclusion 
that 0.75% agarose was most favourable 75. Agarose concentrations within this range 
are used by many laboratories, and by the author of this thesis (final agarose 
concentration of 0.7% is used). Taken together, these findings highlight the importance 
of keeping the agarose concentration constant during a study, i.e. to handle the agarose 
with care and prepare the agarose solution in a strict manner. When pipetting agarose 
solutions, its viscosity should be considered. In addition, storing the agarose in small 
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Figure 7. DNA migration in untreated cells i.e. cells exposed to 0 Gy (filled diamonds) 
and cells exposed to 5 Gy (lines) of γ-radiation measured by the alkaline comet assay 
using different agarose densities. Each increase in agarose density caused a 
significantly decreased DNA migration in cells irradiated with 5 Gy (Student’s t-test, 
where *, ** and *** means P < 0.05, P < 0.01 and P < 0.001, respectively). The linear 
dose-response relationships were significant both for untreated cells (r = -0.71, P < 
0.01, ANOVA) and cells exposed to 5 Gy of γ-radiation (r = -0.95, P < 0.001, 
ANOVA). The slopes of the two regression curves were significantly different (P < 
0.001) from each other. The experiment was repeated 4 times. Each diamond/line 
represent the mean value of 100 scored cells (50 cells from each of two separate gels).  
 
 
An interesting observation within the ECVAG network was that many participants 
reported the agarose concentration before adding the PBS-cell suspension, instead of 
the final agarose concentration. When we specified that the participants should report 
the final agarose concentration in the second round of studies (ECVAG studies 5-7 
described in section 4.2), the results were as expected different. It shall be highlighted 
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5.1.2 Lysis 
The duration of the lysis treatment is widely believed not to influence the outcome of 
the comet assay and differs substantially between different laboratories (often ranging 
from 1h to overnight). A warning is issued in the ‘NewGeneris Comet Assay Protocols 
and other useful information’ 76, regarding that a longer lysis treatment can cause 
detachment of gels. In ECVAG study 5, a long lysis treatment caused detachment of 
gels for several participants (Forchhammer et al., in preparation).  
 
To further avoid possible detrimental factors, Hartmann et al. recommend rinsing of the 
slides before alkaline treatment to remove remaining constituents from the lysis 
solution that may influence the electrophoresis 29. 
 
5.1.3 Incubation time of Fpg and hOgg1 
Before using an enzyme in the comet assay, the investigator should perform a 
titration experiment where the saturation level is assessed by varying the enzyme 
concentration and/or the enzyme treatment time 28. Results in the literature and 
observations in paper II show that investigators at times use far too short enzyme 
incubation 70. The durations of Fpg treatment in paper III were based on the durations 
used by the participants in ECVAG in paper II, where incubation with Fpg was 
performed for 10 min (n = 1), for 25 min (n = 1), for 30 min (n = 5), and for 45 min 
(n = 3) 70. The results indicated that incubation with Fpg for 10 min is inadequate 
whereas 30 min is sufficient to introduce the additional breaks in the DNA 72. 
Dušinská & Collins suggested that an incubation of 30 min appeared optimal already 
in the first Fpg comet assay paper 10. The Fpg used in papers II and III, and by many 
other researchers, is of one batch and concentration, and obtained from A.R. Collins 
(University of Oslo, Norway). Based on this, it can be argued that it is useful to some 
researchers to highlight the importance of the duration of Fpg treatment. Whereas the 
quality of the commercially available Fpg varied a lot in our hands, the enzyme 
produced by A.R. Collins proved to be more stable. Based on unpublished data from 
J. Kain, H.L. Karlsson and L. Möller (Kain, personal communication) it can be 
speculated that the durations of incubation with hOgg1 presented in some 
publications might be too short. Although Fpg recognises a range of additional 
substrates in vitro compared to hOggI, it remains to be seen how biologically 
important and abundant these other lesions are in vivo. A systematic comparison of 
the background levels of hOgg1- and Fpg-sensitive sites in a large biomonitoring trial 
has not been performed to the knowledge of the author of this thesis 77. 
 
The availability of the enzyme is an important aspect for the applicability to the comet 
assay. It is an advantage if the enzyme can be produced through an over-producing 
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plasmid or phage DNA, allowing for mass production of the enzyme by bacteria in a 
cheap and simple way. The use of hOgg1 in the comet assay is far less common as 
compared to Fpg, as it is not available in large quantities 28 and has poor stability in the 
freezer. 
 
5.1.4 Duration of alkaline unwinding and its significance for ALS 
At pH>12.6, ALS are believed to be transformed to strand breaks quickly 78. Tice et al. 
stated in 2000 that 20 min alkaline unwinding is considered sufficient for most 
purposes 31. However, several papers have reported that the DNA migration is affected 
by the duration of alkaline unwinding 79, 80 and Collins points out that it has not been 
rigorously shown that all ALS are converted to strand breaks in the comet assay 81. 
When we analysed the influence on DNA migration by the concentration of Ro and the 
different protocol-steps in paper II, the duration of alkaline treatment significantly 
contributed to both the sum of DNA breaks and Fpg-sensitive sites (P < 0.01), and net 
Fpg-sensitive sites (P < 0.01) 70. The statistical significance remained when using a 
statistical model with solely the concentration of Ro and the duration of alkaline 
treatment 70. Typically, 20-40 min of alkaline unwinding is applied 70, but 60 min 
alkaline unwinding was also included in paper III, since findings by Vijalaxmi et al. 
indicated that there is an increased level of DNA migration after 60 min alkaline 
treatment in cells exposed to γ-radiation 80. Similarly, we observed in paper III that the 
duration of the alkaline unwinding (20, 40 and 60 min, respectively) affected the extent 
of the DNA migration in cells exposed to 5 Gy of γ-radiation 72. In cells exposed to Ro 
and light, which is believed to mainly induce 8-oxoguanine 82, there was a significant 
difference in DNA migration between cells exposed to 40 and 60 min of alkaline 
unwinding 72. In H2O2-treated cells, however, we observed a significant difference in 
DNA migration when prolonging the alkaline unwinding from 20 to 40 min, whereas 
increasing the time an additional 20 min to 60 min did not affect the outcome 
significantly (Student’s t-test) 72, which is in accordance with findings by Azqueta et al. 
74. We did, however, observe a highly significant dose-response relationship between 
20-60 min alkaline unwinding (ANOVA) in cells exposed to both H2O2 and 5 Gy, as 
well as a significant dose-response relationship in cells exposed to Ro and light 72. The 
DNA migration in undamaged cells was not affected by the duration of alkaline 
treatment 72. Taken together, these results indicate that cells exposed to γ-radiation, Ro 
and H2O2 contain ALS, and that not all of these ALS have been converted to strand 
breaks after 20 or 40 min of alkaline treatment 72. The significantly different slopes of 
the untreated and treated cells indicate that the sensitivity of the method could be 
improved by altering the duration of the alkaline treatment 72. Typically used durations 
of alkaline treatment might be inadequate, provided that one wants to measure these 
ALS. Speit & Hartmann suggested that durations of alkaline treatment and 
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electrophoresis should be adjusted to obtain valid and reproducible results for each cell 
type 83. We do not know the nature of these ALS that seem to be resistant to alkaline 




5.1.5.1 Strength of the electric field 
It is commonly known that the strength of the electric field (the electric potential) 
affects DNA migration in a linear way during electrophoresis. However, due to the 
particular circumstances in the comet assay, where strand breaks allow relaxation of 
DNA loops and allow them to extend towards the anode, this is not necessarily true for 
the comet assay. Without strand breaks there is hardily any DNA migration irrespective 
of the sensitivity of the protocol. We observed in paper III that the strength of the 
electric field did not have a statistically significant impact on cells exposed to 0 Gy 
(untreated cells) (figure 8) 72. When damage is present, on the other hand, significantly 
different slopes of the regression curves for the different strengths of the electric field 
indicate that the sensitivity of the comet assay can be improved by altering the strength 
of the electric field (figure 8) 72. However, applying a too weak or a too strong electric 
field is not recommended. Applying an electric potential of 0.70 V/cm in paper III 
resulted in very short comet tails in all cells. Azqueta et al. recently demonstrated that 
H2O2-treated cells behave like untreated cells when an electric potential of 0.16 V/cm is 
applied, i.e. there is virtually no migration at all 74. Thus, it seems that when the 
strength of the electric field is insufficient, the DNA does not migrate, i.e. some DNA 
loops have not extended out from the comet head resulting in an underestimation of 
DNA damage. An electric potential of 1.60 V/cm, on the other hand, resulted in very 
long comet tails, which were difficult to score due to difficulties defining the comets 
head and tail 72. Azqueta et al. faced the same scoring difficulties when analysing 
H2O2-treated cells using an electric potential of 1.48 V/cm, and described it as comet 
tails being detached from the comet heads 74. When a large fraction of the DNA is in 
the comet tail, the DNA migration could end up outside the range of linear detection, 
i.e. not more than ~80% of the DNA should be in the tail 84. When applying 1.60 V/cm 
in the analysis of cells irradiated with 7.5 Gy of γ-radiation in paper III, the range of 
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Figure 8. DNA migration in cells irradiated with different doses of γ-radiation 
measured with the alkaline comet assay using different strengths of the electric field 
(0.70, 1.15 and 1.60 V/cm) during electrophoresis. The DNA migration was 
significantly increased (P < 0.001, two-way ANOVA) when comparing 1.60 V/cm 
(closed circles) to 1.15 V/cm (lines) and when comparing 1.15 V/cm to 0.70 V/cm 
(filled diamonds) and the slopes of the regression curves were significantly different 
from each other (P < 0.001). The linear dose-response relationship (r = 0.99 for all 
strengths of the electric fields) was highly significant for all curves (P < 0.001, 
ANOVA). The experiment was repeated 3 times. Each diamond/line/circle represents 
the mean value of 100 scored cells (50 cells from each of two separate gels). 
 
In the ‘NewGeneris Comet Assay Protocols and other useful information’, it is 
suggested as a rough guide to use about 1 V/cm with a layer of 1-2 mm of buffer above 
the slides 76. Although a linear dose-response relationship was observed for the electric 
field when investigating 0.70, 1.15 and 1.60 V/cm in paper III (figure 8), one should be 
careful to draw any general conclusions regarding a linear dose-response over this 
entire interval. There is not necessarily a linear dose-response relationship between for 
example 1-1.2 V/cm.  
 
Ampere (A) or voltage (V) is often reported in scientific papers when describing the 
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range of different electrophoresis tanks with different sizes and proportions available, 
this is quite uninformative. It is more accurate to report the voltage gradient over DNA 
(V/cm) since it is this gradient that causes the DNA to migrate 26. Prof. G. Brunborg 
(National Institute of Public Health, Oslo, Norway) has prepared an Excel sheet 
(available online) that returns the V/cm based on the physical dimensions of the tank 
(inner dimensions and length of platform), the power supply (voltage and current) and 
buffer characteristics (amount, conductivity, pH, temperature and molarity of the 
buffer) 85. This Excel sheet was used in papers I and II, albeit some designs of the 
electrophoresis tanks were more difficult to apply to the data sheet than others. It is a 
good approximation to divide the voltage with the length of the platform in the 
electrophoresis tank since the voltage drop between the platform and the electrodes is 
very small compared to above the platform 26. During the preparation of papers I and II 
it was discovered that there was a lack of consensus regarding how to calculate the 
voltage gradient and it seems to be a common misunderstanding that the V/cm should 
be based on the distance from the anode to the cathode. Investigators should make sure 
that the voltage gradient is kept constant during a study. In a recent article by Azqueta 
et al., the authors question the accuracy of calculating V/cm both across the platform 
and from anode to cathode 74. By measuring the actual voltage potential on the platform 
(by a jig equipped with platinum probes set 10 cm apart on, and 0.7 mm above the 
platform) the authors demonstrated that the real voltage potential differed substantially 
from the V/cm calculated from both the anode to cathode and across the platform 74. 
This leaves an even greater confusion about how to report the electric potential. Due to 
the confusion regarding V/cm, and to the great diversity of the physical dimensions of 
the electrophoresis tanks used by the different ECVAG collaborators, we chose not to 
include the strength of the electric field in the multiple regression models in paper II. 
 
5.1.5.2 Duration of Electrophoresis 
The duration of electrophoresis affected both the sum of DNA breaks and Fpg-sensitive 
sites (P < 0.01) and the net Fpg-sensitive sites (P < 0.001) in paper II (multiple 
regression analysis) 70. This supported previous findings by Forchhammer et al. 79. 
Again, in paper III, it was shown that the duration of the electrophoresis significantly 
affected the outcome of the comet assay (figure 9) 72. It is possible that the significantly 
steeper slope in figure 9 reflects an increased level of converted ALS into strand breaks 
in the cells that have been irradiated to higher doses of ionising radiation. Since 
electrophoresis is performed in the same alkaline solution as alkali unwinding, it can be 
speculated that the increased duration of alkaline treatment affects the outcome more in 
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Figure 9. DNA migration in cells irradiated with different doses of γ-radiation 
measured with the alkaline comet assay with 20 or 30 min of electrophoresis. The DNA 
migration was significantly increased (P < 0.001, two-way ANOVA) when running 
electrophoresis for 30 min (lines) compared to for 20 min (filled diamonds), and the 
slopes of the two regression curves were significantly different from each other. The 
linear dose-response relationships for both curves were highly significant (r = 0.99, P < 
0.001, ANOVA). The experiment was repeated 4 times. Each diamond/line represent 
the mean value of 100 scored cells (50 cells from each of two separate gels). 
 
 
5.1.6 Scoring of comets 
The relative magnitude of the intensity of the comet tail provides information about the 
number of relaxed loops, which reflect the level of DNA damage 42, 67. The comets are 
analysed either by visual or computerised scoring. The different ways of scoring cells 
have different advantages and weaknesses. Visual scoring and computerised scoring 
have been shown to correlate to each other 8, 58, 86. The recently developed automatic 
computerised scoring is completely automatic compared to the time-consuming 
computerised analysis, which requires that an investigator watches and selects the 
comets to be analysed. Azqueta et al. recently compared visual scoring, computerised 
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scoring methods are thrust-worthy and that results obtained by the three methods to a 
large extent can be interchangeable 54. Advantages with visual scoring are that it is 
faster than computerised scoring (when performed by an experienced investigator) and 
that cells in close proximity to each other can be scored. Drawbacks of visual scoring 
are that the method suffers from overestimation of low levels of damage 54 and that 
different investigators have reported different levels of DNA migration when scoring 
the same slides 87, 88. However, in a study by Møller et al., it was clear that the 
investigators with most experience showed the lowest levels of variation 88. In this 
context, it should be emphasised that the participants in ECVAG reported substantially 
different levels of DNA migration (%DNA in tail) in the pre-made slides in paper I 
using computerised image analysis 69. Although these pre-made slides were not the 
same set of re-stained slides, they were prepared in the same laboratory using a fixed 
protocol.  
 
When working with computerised scoring, it is important that the density of cells in the 
gels is appropriate. Cells shall neither be ‘selected’ nor ‘excluded’ by the investigator. 
A high density can give artefacts since overlapping cells or cells in close proximity 
cannot be scored (causing a ‘selection’), whereas a low density will make the scoring 
time-consuming and difficult. One should make sure that the same cell is not scored 
more than once. This can be achieved for example by scoring all cells encountered in ‘a 
row in the gel’ until a specific amount of cells has been scored. When using 
computerised scoring, the software program recognise the head and the tail of the 
comet, but the investigator can change the borders of the head and tail if the program 
fails to do so properly (which is not uncommon). Also, when a cell in close proximity 
falls into another cell’s ‘background’, the investigator can adjust the microscope slide 
to enable the comet to be scored. Investigators have noted that comets located in the 
outer areas of the agarose gel are sometimes more damaged and in order to avoid edge 
effects, it is better to avoid scoring too close to the gel edges. 
 
The findings in paper I imply that the image analysis (and possibly staining) affects the 
outcome of the comet assay 69. We suspect that this is related to different settings in the 
image analysis system. However, it cannot be completely excluded that different stains 
have affected the outcome. For example, EtBr intercalates between base pairs whereas 
DAPI binds in the minor groove 26, which possibly might affect the relative intensity 
between the comet head and comet tail, since the latter consists of more single-stranded 
DNA. Also, stains differ in photostability 75. In study 5-7 in ECVAG, this question was 
addressed by distributing pictures of different classes of comets together with 
information on approximate values of %DNA in the tails. The participants were 
instructed to change the settings of their image analysis software if the results deviated 
from these images. However, it can be expected that investigators will be reluctant to 
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change such settings, especially if originally adjusted by manufacturers to optimal 
conditions. Taken together, there were too many different image analysis programs and 
stains used to statistically verify their influence in the ECVAG trials.  
 
5.1.7 Used solutions/buffers 
It is clear that the alkaline (pH>13), the low alkali (pH∼12.3), and the neutral comet 
assay affect the endpoint. However, as observed in paper II, most researchers now use 
similar solutions in the alkaline comet assay, e.g. lysis solution (2.5 M NaCl, 0.1 M 
EDTA, 10 mM Tris, pH 10), Fpg enzyme buffer (40 mM HEPES, 0.1 M KCl, 0.5 mM 
EDTA, 0.2 mg/ml bovine serum albumin, pH 8.0) and alkaline solution (0.3 M NaOH, 
1 mM EDTA, pH>13). Some of the participants in ECVAG have reported that their 
alkaline buffer had pH=13 and some reported that it had pH>13. Many pH meters are 
not calibrated to measure such a high pH, and since the same alkaline solution (0.3 M 
NaOH, 1 mM EDTA) was used by participants, it was assumed that the pH was the 
same in all laboratories in papers I and II. 
 
5.1.8 The influence of temperature 
Speit et al. observed that the duration of alkaline treatment and electrophoresis time 
influenced the DNA migration, but also that the employed temperature drastically 
affected the outcome 73. When comparing 4°C with room temperature (20°C), a 
substantial increase of DNA migration was seen at room temperature suggesting that 
temperature is a major parameter affecting the sensitivity of the comet assay 73. The 
authors concluded that the assay has to be performed under constant and reproducible 
conditions 73. In the laboratory of this author, this is achieved by always performing 
lysis and alkaline treatment at 4°C and by employing an electrophoresis tank that is 
chilled by ice-cold water circulating under the platform. Analysis performed at room 
temperature would be made difficult due to temperature variations during seasonal 
changes. 
 
5.2 UNITS  
The most frequently used units for computerised scoring are %DNA in tail, tail 
moment and tail length. Collins et al. have recommended the use of %DNA in tail, 
since it is linearly related to break frequency over the widest range of damage and 
linearity is needed in order to calculate net enzyme-sensitive sites 26. Tail length is 
linear at low levels of damage 89 but a drawback is that it is only linear in a very narrow 
interval 9. Collins et al. also argues that the tail length can differ between species and 
tissues 26. We observed in paper I that tail length was a poor unit that did not even allow 
for detection of dose-response in the pre-made slides 69. A difficulty with tail moment 
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is that it can be calculated in different ways, e.g. ‘tail extent moment’ being the product 
of %DNA in tail and the tail length, or the ‘olive tail moment’ being the product of 
%DNA in tail and the distance of centre of gravity between head and tail 90, 91. In both 
cases, tail moment is based on tail length, so a deviance from linearity in tail length will 
affect the linearity of tail moment as well. The dose-response relationships in the pre-
made slides obtained by %DNA in tail or tail moment did not differ significantly from 
each other in paper I 69. 
 
An observation within ECVAG is that scientists seem to have rather strong opinions 
regarding whether it is more appropriate to report %DNA in tail as a median or mean 
value. The distribution of damage in γ-irradiated cells is homogenous, whereas (for 
example) exposure to particles can lead to a heterogeneous distribution i.e. some cells 
might be undamaged whereas some are very damaged 92. In the latter case, a ‘median’ 
value, could conceal the effect. On the other hand, Speit & Hartmann suggest that since 
the damage levels in the individual cells are frequently not normally distributed, 
median is the preferred unit 83. ‘Mean’ might give excessive weight to heavily damaged 
comets, e.g. when most cells have 5% of the DNA in the tail except one or a few 
comets that have 95% of the DNA in the tail. Also, some cell types might have more 
heterogeneous distributions than others. In experience of this author, cultured cells 
frequently have a more homogenous distribution than PBMC. In addition, H2O2-
treatment of lymphocytes results in a relatively heterogeneous distribution of damage 
54. One reason for this heterogeneous result could be that PBMC are frequently isolated 
using gradients and PBMC isolated in this manner consist of different cell-types (but 
mainly lymphocytes). Cells of for example different age or in different stages of the 
cell cycle can also respond differently. Azqueta et al. recommends that median should 
be used for most comet results 54. When the level of damage in the analysed cells is 
very heterogeneous, it can for example be appropriate to report results as distribution 
patterns using histograms 93. Experienced scientists are likely to be able to judge which 
endpoint/endpoints (mean, median or a distribution pattern) are most appropriate for a 
particular dataset. The possibility to measure heterogeneity in response (to detect the 
response in individual cells) is an advantage with the comet assay, and it is important 
not to loose valuable information when reporting data. 
 
5.3 REFERENCE STANDARDS 
Experimental variation can be decreased by calibration with ionising radiation or by 
using internal standards. 
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5.3.1 Calibration curves 
By calibration with γ-rays or X-rays, primary comet assay endpoints, e.g. %DNA in 
tail, tail moment and arbitrary units, can be reported in ‘real’ damage levels, e.g. 
lesions/106 bp, lesions/109 Dalton DNA, lesions/cell or Fpg-sensitive sites/106 
guanines. Before starting to discuss the problems with calibration curves, it should be 
stressed, nonetheless, that calibration by protocol-specific calibration curves is a 
powerful and useful tool with which to reduce variation 72. In addition to facilitating 
comparisons between studies that have used different protocols, ‘real’ units is easier to 
understand for individuals who are not familiar with the comet assay compared to 
primary comet assay endpoints. The benefits of calibration are easy to understand, but 
there are also some methodological problems that should be mentioned. 
Methodological difficulties with standard curves include; a) it is laborious, b) an 
ionising radiation source is required, c) it is possible that the type, energy and quality of 
the radiation source can affect the outcome, d) repair (or induction) of DNA-damage 
should be prevented, and, e) the accuracy of the assumed amount of DNA breaks that is 
formed per Gy might be questioned. Also, in papers I and II, it was observed that there 
was a tendency to approach saturation at 10 Gy, seen as deviation from linearity for 
some laboratories at this radiation dose, which indicated that the upper limit of 
detection had been reached. This is in accordance with observations by others 94. The 
sensitivity of the respective protocols should to be taken into consideration when 
selecting the dose-range of the calibration curve. In the ECVAG studies 4-7, the dose 
range used in the calibration curves was modified to 0-7.5 Gy. 
 
Including reference curve standard samples is laborious, and since the limitation of the 
comet assay often is the size of the electrophoresis tank, including reference standards 
might mean that some other important samples have to be excluded. However, the 
emerging high-throughput systems using mini-gels and automatic scoring minimise this 
problem.  
 
Differences in calibration curves between laboratories, i.e. in the level of DNA 
migration caused per Gy, have been highlighted before, and this has been suggested to 
depend on protocol differences and the use of different radiation sources, which can 
differ in type, energy and quality 26. Also, strand breaks can be repaired quickly, and 
the handling of cells until lysis, where all repair is terminated, has been shown to affect 
the standard curves 26. Exposure to radiation (and other substances) after embedding the 
cells in gels can be used to better prevent repair 26. For PBMC, DNA damage can be 
induced or repaired during isolation of PBMC (during collection, transportation, 
centrifugation and washing) or during the handling of cells until lysis (during thawing, 
centrifugation, washing and gel preparation). In papers I and II, where cell cultures 
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were used and one laboratory prepared and froze the samples, it is likely that the 
differences that were observed were mostly attributed to differences in protocols and 
settings in the analysis systems 69, but they could also in part be due to different 
procedures for thawing and washing. It was observed in papers I-III that the calibration 
curves did not completely remove the influence of the different protocols 72. In paper 
III, we speculate that relative amounts of different types of damage influence samples’ 
sensitivity to duration of alkaline treatment and electrophoresis. Already in 1992, 
Vijayalaxmi et al. speculated that γ-irradiated cells contain ALS that are relatively 
resistant to high alkaline treatment 80. The results in paper III indicate that the typically 
applied 20 or 40 min of alkaline treatment might not be sufficient to convert all ALS 
into strand breaks in γ-irradiated cells. Calibration curve samples that contain ALS that 
are relatively resistant to alkaline treatment will make the accurateness of the 
transformation of damage levels into ‘real units’ vulnerable to the length of alkaline 
treatment and electrophoresis. The samples that one wants to investigate might also 
contain these types of ALS making them sensitive to the length of the alkaline 
treatment and electrophoresis.  
 
5.3.2 Transformation of units in papers I-III 
When converting DNA damage into ‘real units’, assumptions are made regarding the 
amount of strand breaks caused per Gy of ionising radiation. When converting %DNA 
in tail and a.u. into real strand breaks in the ECVAG studies, an average of two 
estimations of the amount of strand breaks that is caused per Gy was used. The amount 
of strand breaks per 109 Dalton DNA caused per Gy was estimated to be 0.27 by Kohn 
et al. 95 and 0.31 by Ahnström & Erixon 96, using the alkaline sucrose sedimentation 
technique. In the ESCODD studies, the conversion was based only on the latter 
estimation. However, the difference between these assumptions should not be 
exaggerated, and it was actually shown in paper I that ESCODD’s calibration curve and 
an average of the ECVAG participants’ calibration curves were virtually the same 69. 
However, it is worth noting that there is different ways to estimate ‘real’ units of 
damage. Also worth noting is that not all conversions are based on standard curves 
performed by the ‘own’ protocol 88. Because of substantial influence on DNA 
migration by protocol (paper III), and that conversion of primary comet assay endpoints 
by ‘own’ calibration curves are superior to a common calibration curve (paper I), i.e. 
using the ‘own’ calibration curves decreased the inter-laboratory CV from 47% to 28%, 
it is strongly recommended to use a standard curve performed with the ‘own’ protocol 
when converting primary comet assay units. The formula that was used to transform the 
DNA migration into real units in papers I-III is described in papers I and II 70.  
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The two cell lines used in papers II-III (A549 and HTP-1) are of different genome size. 
To use different cell lines was originally a mistake, and the issue has been extensively 
discussed within ECVAG. Based on the partners’ past experience, the genome size of 
the irradiated cells does not affect the DNA migration (%DNA in tail) since irradiation 
‘saturates the DNA’, e.g. causes 0.29 lesions/109 Dalton DNA, disregarding of the 
amount of DNA. Therefore, it was decided that the conversion into real units should 
not take the genome size, e.g. the different cell types, into account.  
 
5.3.3 True internal standard 
An alternative to calibration curves is using internal reference cells. Zainol et al. (study 
4 in ECVAG) have developed distinguishable reference cells that can be embedded in 
the same gels as the investigated test cells 71. By replacement of thymidine by 
bromodeoxyuridine, and applying a fluorescently tagged anti-bromodeoxyuridine 
antibody together with an additional filter, the reference cells can be distinguished from 
the test cells 71. Zainol et al. showed that the intra-experimental and inter-experimental 
variation was greatly improved by using these internal standards and that this effect 
partly was attributed to the correction of inter-gel variability 71. 
 
5.4 STANDARDISED PROTOCOL 
Whether results in different studies could be directly compared when a standardised 
protocol is used needs to be elucidated. In ECVAG study 5, a set of reference 
conditions will enable comparisons between laboratories without the impact of some 
particularly critical protocol differences (Forchhammer et al., in preparation). 
Preliminary statistical analyses from ECVAG study 5 indicate that it is possible to 
decrease, but not completely remove, the inter-laboratory variation by using reference 
conditions, i.e. fixed solutions, agarose concentration, enzyme conditions, duration of 
alkaline treatment, duration of electrophoresis and strength of the electric field 
(Forchhammer et al., in preparation). However, it should be emphasised that only a few 
protocol parameters were standardised in the ECVAG study 5, and the reference 
conditions cannot be considered to be a standardised protocol.  
 
It is unlikely that investigators could be persuaded to change their own procedures 
radically and start to use a standardised protocol. In addition, although the lack of a 
standardised protocol often is regarded as a problem, it can also be an advantage for the 
experienced investigator that the protocol can be adjusted to improve sensitivity or to 
suit the composition of different DNA lesions or cell types containing DNA with 
different compactness. The compactness of DNA differs between cells. Cell types that 
are exposed to a harsh environment have a more compact DNA. Sperm cells, for 
example, have a six times more compact DNA than somatic cells 38. 
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5.5 RANGE OF DETECTION 
Even though the range of detection in the comet assay is quite narrow, it is very well 
suited for investigating normal background levels of DNA damage and damage caused 
by non-lethal exposure to different compounds (approximately a hundred to several 
thousand breaks) 26. The upper limit of the comet assay is due to that once all DNA is 
in the tail the method is saturated. But even before this occurs, there is a deviation from 
linearity. The comet assay is linear up to approximately 80 %DNA in tail 84. DNA 
break frequency is linear to %DNA in tail up to approximately 2.5 breaks per 109 
Dalton DNA 9. When using enzymes in the comet assay for simultaneous measurement 
of DNA breaks and enzyme-sensitive sites, it is important that the saturation level for 
the sum of DNA breaks and enzyme-sensitive sites is not reached in order for the net 
enzyme-sites to be correct, i.e. linearity is required for correct calculations of net 
enzyme-sensitive sites. Comet assay’s detection limit for ionising radiation has been 
reported to be as low as 0.05 Gy 89 and 0.006 Gy 97. Based on the assumption that 1160 
strand breaks are created per Gy in diploid cells, this would correspond to 58 and 7 
strand breaks, respectively. 
 
5.6 SPECIFICITY OF THE USED REPAIR ENZYMES 
The enzyme comet assay is often regarded as being less specific when measuring 
oxidative DNA lesions than HPLC based techniques due to that the used enzymes 
(such as Fpg) recognise a range of different damages. However, ESCODD showed that 
comet assay is superior at measuring oxidative DNA lesions compared to both HPLC 
based techniques and GC-MS techniques 67. One should keep in mind, however, that 
the enzymes generally recognise several other lesions in addition to their main substrate 
(described in section 3.2.4). For example, Ro and light, which was used in both 
ESCODD and in papers II and III, is assumed to mainly induce 8-oxoguanine. Pflaum 
et al. treated phage DNA with Ro and estimated that 74% of the Fpg-sensitive sites 
were 8-oxoguanine by using HPLC and the Fpg alkaline elution method 98. In a similar 
way, Will et al. estimated that 69% of the Fpg-sensitive sites caused by Ro and light 
were 8-oxoguanine 82. Ro predominantly produces singlet oxygen (1O2), which could 
be expected to generate relatively few DNA breaks 66, 82. Thus, the Fpg-sensitive sites 
detected in papers II and III is likely to include other oxidatively modified DNA-bases 
in addition to 8-oxoguanine. The observed DNA breaks caused by exposure to Ro in 
paper II could reflect intermediate stages of repair of oxidative DNA damage.  
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5.7 SPECIFICITY OF THE COMET ASSAY 
Do we know what we measure with the comet assay? This question can be interpreted 
in several ways, and different aspects of the specificity of the comet assay have already 
been mentioned. Different types of the comet assay clearly measure different lesions, 
e.g. the neutral comet assay measures strand breaks, whereas the alkaline comet assay 
measures strand breaks and ALS. In the enzyme versions of the comet assay, the 
applied enzymes frequently recognise a main substrate and lower levels of a range of 
other lesions (section 3.2.4). New base damages recognised by the applied enzymes 
will most likely continue to be discovered. It is also worth noting that although the 
basic alkaline comet assay is most frequently used, only a few genotoxic agents induce 
DNA strand breaks directly. Strand breaks are, however, often formed as intermediates 
during the repair process of other DNA lesions 30. Apurinic and apyrimidinic (AP) sites 
formed as repair intermediates are alkali-labile, but it has not been established whether 
the alkaline treatment will cause a conversion of all AP sites to strand breaks 28. AP 
sites are an intermediate during BER but can also be formed by other means. Different 
agents cause different types or patterns of DNA damage and it is important to use 
appropriate methods to assess the DNA damage.  
 
In the past, the comet-tail was often said to consist of DNA fragments, whereas 
nowadays it is often said to consist of relaxed DNA loops. Observations that the comet-
tail is often of a particular length (75 µm), which is in accordance with the estimated 
loop length of 220,000 bp, support the loop theory 26. A break in a DNA loop will relax 
the supercoiling and allow the loop to migrate towards the anode. However, the loop 
theory does not exclude that the comet-tail also consists of DNA fragments, created by 
several breaks in a loop. Very long tails and tails that are detached from the comet head 
observed by Ersson & Möller 72 and Azqueta et al. 74, indicate that the comet tail also 
consist of DNA fragments. 
 
PBMC is extensively used in studies employing the comet assay due to availability, but 
they are not targets for cancer. Since they circulate through the body they are assumed 
to reflect the organism’s overall state 26. However, whether it is appropriate to draw 
conclusions regarding tissues where cancer often develops from PBMC is a valid 
question. We observed in a recent study on salivary glands in patients with chronic 
kidney disease (CKD) that tissues and circulating cells seem to be differently affected 
in this patient group 99, although one should be careful to draw any general conclusions 
from this patient group. The internal environment in these patients is in many ways 
extreme and for those patients who undergo haemodialysis (HD), PBMC are forced 
through a dialysis machine exposing them to additional stress. 
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5.8 TRANSFORMING THE COMET ASSAY INTO A HIGH-
THROUGHPUT ASSAY 
The normal alkaline comet assay protocols currently employed is too laborious to be 
applicable to large studies with hundreds or thousands of samples. High-throughput 
protocols are needed in order to make the comet assay suitable for large biomonitoring 
studies and to study effects of for example single nucleotide polymorphisms (SNPs) 81. 
The most important limitations are probably the time-consuming scoring and the size of 
the electrophoresis tank, which limit the number of slides that can be analysed at each 
analysis occasion. The network for comet assay and cell array for fast and efficient 
genotoxicity testing (COMICS) is developing a high-throughput protocol of the comet 
assay using mini-gels and completely automatic computerised scoring. Automatic 
computerised scoring have been shown to be equally good at finding low levels of 
damage as computerised scoring 54. However, the automatic scoring program have 
difficulties to find heavily damaged comets 54. Although completely computerised 
automatic scoring is a very promising tool, general applicability is prevented by the 
program’s price tag. 
 
Conventional microscope slides usually contain 1-3 gels per slide. Shaposhnikov et al. 
have developed a custom-made silicone gasket, which allow incubation of 12 mini-gels 
per slide with different solutions 37. In this way, either substantially more samples, or 
samples incubated with several enzymes simultaneously, can be analysed in a single 
experiment 37. The authors showed that results obtained by using 12 mini-gels per slide 
were comparable to results obtained by using two gels per slide 37. The mini-gel system 
allows simultaneous electrophoresis of more samples, but it also saves time at all stages 
during the assay since less slides need to be handled and less reagents and solutions are 
needed 37.  
 
5.9 POSSIBLE INTERACTION BETWEEN PARTICLES AND THE COMET 
ASSAY 
When analysing DNA damage caused by particles with the comet assay, investigators 
have found clearly visible particles in the nucleoid, although no such particles could be 
seen in the cell nuclei when using transmission electron microscopy 92, 100, 101. Karlsson 
states that it seems like intracellular particles can gain access to DNA after lysis when 
performing the comet assay 100. Recent findings by Kain et al. indicate that several 
particle types interact with the repair enzyme Fpg during the comet assay (Kain et al., 
in preparation). The nature of this interaction is a matter of speculation. Fpg is a so-
called zinc finger protein, and the active site of the Fpg contains a zinc atom 
surrounded by four SH-groups. Some metal ions such as cadmium(II) and cupper(II) 
have been observed to be able to inhibit the enzyme’s activity, as it seems by 
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competing with zinc for its position in the active site 102. Kain et al. observed that a 
range of metals caused a decreased enzyme activity and that silver completely 
inactivated the enzyme, and suggest that silver particles or ions might bind to the SH-
groups in the active site (Kain et al., in preparation). Fpg is probably not the only repair 
enzyme sensitive to metals. Several metals including cadmium, manganese, arsenic, 
chromium and lead have been reported to decrease Ogg1 activity although the 
mechanisms of action are not fully elucidated 103. These observations taken together 
indicate that particles might interact with the comet assay. 
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6 DNA REPAIR AND THE MUTAGENIC PROPERTIES 
OF DNA DAMAGE 
DNA lesions can be used as biomarkers of the biologically effective dose of, for 
example, environmental mutagens or for identification and assessment of different 
hazardous or protective agents. However, in order to say that DNA damage is a 
biomarker of cancer risk, this has to be shown in prospective studies, and so far this has 
not been done for the biomarkers measured with the comet assay. But we know that 
when DNA damage is left unrepaired, it can lead to mutations, and mutations that are 
located in the wrong place in the genome can contribute to cancer. DNA repair also 
plays a crucial role in the long and windy path from DNA lesions to cancer. The 
relationship between DNA damage and DNA repair is complex and much remains to 
be elucidated concerning both how this relationship is influenced by gene-environment 
interactions and by interactions by endogenous factors. Environmental and 
occupational exposure to chemicals can potentially not only affect DNA lesions but 
also DNA repair 58. The first section in this chapter highlights the gradual development 
of cancer and the many protective pathways that need to fail in order for the disease to 
develop. In the second section of this chapter, the mutagenic potential of DNA damage 
(mainly 8-oxoguanine) is discussed. The following sections deal with DNA repair with 
the focus on the repair of 8-oxoguanine and an application of comet assay; the in vitro 
comet BER assay, which is a new promising tool to measure DNA repair.  
 
6.1 OXIDATIVE STRESS AND CANCER 
Oxidative stress is associated with both inflammation and cancer. Inflammation is a 
response to harmful or injurious stimuli, be it from foreign or endogenous sources, 
and involves the vascular, as well as immune system. Macrophages formed during 
inflammation are capable, under the right conditions, of releasing more than hundred 
substances, including ROS, into the tissue environment to fend off or protect against 
invading pathogens 104. The consequences of the inflammatory process, such as the 
formation of ROS, can also lead to damage to the surrounding cells because reactive 
compounds are indiscriminating. Some of these damages may occur in such a way 
that they alter cellular function of surviving cells and with time, additional damage 
may accumulate and lead to development of disease. 
 
Cancer develops gradually under a long period of time and at least six major 
pathways protecting the cell must be altered for a cancerous tumour cell to form. 
These include a) self-sufficiency in growth signals, b) insensitivity to anti-growth 
signals, c) invasion of apoptosis, d) tissue invasion and metastasis, e) sustained 
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angiogenesis, and f) limitless replicative potential 105. Development of cancer is very 
complex and one must remember that although genetic alterations are important, 
there are many pieces in the puzzle.  
 
6.2 MUTAGENIC PROPERTIES OF DNA DAMAGE 
Chromosome aberrations and micronucleus formation are considered to be biomarkers 
of early biological effects, reflecting a later step of carcinogenesis compared to 
biomarkers of exposure 8. Chromosomal aberrations and micronucleus frequency have 
been shown to predict cancer risk in prospective studies 106-108. Whether DNA lesions 
measured by the comet assay predict cancer risk in prospective cohort studies in a 
similar manner remains to be evaluated 8. The biomarkers measured by the comet assay 
are assumed to provide information about the biologically effective dose 8, and it has 
been shown that comet assay is effective in identifying carcinogens from non-
carcinogens 24, 25. The mutagenic properties differ substantially between different types 
of DNA lesions. 
 
6.2.1 The pro-mutagenic potential of 8-oxoguanine 
Guanine has a lower redox potential than the other three bases, which makes it 
particularly susceptible to oxidation 109. Some of the most common base oxidation 
products are shown in figure 4. A radical attack at the 8’-carbon of guanine gives the 
oxidation product 8-oxoguanine (figure 10), which is the most commonly measured 





Figure 10. Chemical structures of guanine and the oxidation product 8-oxoguanine. 
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The extensive interest in 8-oxoguanine by the scientific community is related to both its 
abundance and its pro-mutagenic potential. Whereas the replication is stalled or 
inhibited at many other DNA base lesions by the polymerase error detection 
mechanisms, 8-oxoguanine is pro-mutagenic and can induce a G-C to T-A transversion 
during DNA replication 112, 113. 8-oxoguanine pairs with cytosine in the regular anti 
conformation, but can in its syn conformation form a stable base pair with adenine 45, 
112. X-ray crystal structures of a DNA polymerase I fragment from Bacillus 
stearothermophilus indicate that adenine is preferred to cytosine opposite 8-oxoguanine 
during replication, since pairing with cytosine disrupts the active site of DNA 
polymerase in a similar manner as recognition of a mismatch in undamaged DNA and 
thereby inhibit further DNA synthesis 112. With other words, incorrect mutagenic 
pairing of 8-oxoguanine with adenine can fool the polymerase error detection 
mechanisms to be treated as a normal base pair 112. Although most DNA polymerases 
misincorporate adenine opposite 8-oxoguanine at relatively high frequencies, there are 
exceptions. Kirouac & Ling recently showed that the specialised human Y-family DNA 
polymerase iota (polι) does not 114. The syn conformation of 8-oxoguanine does not 
form a stable base pair with adenine in the narrow active sites of polι, and the correct 
cytosine is incorporated opposite 8-oxoguanine with a high specificity, albeit with a 
reduced incorporation efficiency compared to opposite undamaged guanine 114. 
Fortunately, organisms have developed a second line of defence against 8-oxoguanines 
that are mispaired with adenines, where the latter can be removed followed by 
subsequent removal of 8-oxoguanine (as described in section 6.4). As a result of the 
efficient repair of 8-oxoguanine, the mutation frequency of 8-oxoguanine in 
mammalian cells are relatively low (a few percent).  
 
This thesis focuses on 8-oxoguanine since it is the main substrate of Fpg that have been 
used in papers II-V. However, 8-oxoguanine is not the only DNA lesion that has pro-
mutagenic properties. For example, RNS can cause deamination of bases. When 
hypoxanthine is formed from adenine, the damaged base can mispair with cytosine 
instead of with thymine as intended. Uracil, which is formed by deamination of 
cytosine can pair with adenine instead of guanine 3. Other oxidative DNA lesions with 
mutagenic potential include for example 5-hydroxycytosine and 5-hydroxyuracil 47. 
The two hydantoin products, spiroiminodihydantoin and 5-guanidinohydantoin, are 
other oxidative modifications of guanine shown to be pro-mutagenic 45. The mutagenic 
properties of different DNA lesions is widely assumed to depend on DNA repair since 
DNA damage that is repaired does not lead to mutations.  
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6.3 DNA REPAIR  
Simplistically, one can say that most oxidative lesions, as well as strand breaks, are 
repaired by BER, bulky lesions are repaired by NER, replication errors (mismatches) 
are repaired by mismatch repair, and double strand breaks are repaired by homologous 
recombination or non-homologous end-joining. It is not the aim of the author of this 
thesis to review these repair pathways. The focus in this section is on the repair of 8-
oxoguanine. 
 
6.3.1 Base excision repair (BER) 
Human cells’ efficiency in repairing DNA damage as well as the type of repair 
mechanism that is mainly used depends on the type of DNA damage. The BER is the 
major pathway for removal of damaged bases, which is performed by several enzymes 
in cooperation. In the general pathway for short-patch BER, the damaged base is 
removed by a glycosylase causing an abasic site followed by cleavage of the DNA 
backbone by either AP-endonuclease, or by an AP-lyase activity that is attached to the 
glycosylase. Following this, polymerase β, which also contains an associated lyase 
activity, inserts the correct nucleotide into the DNA strand. The remaining nick on 
DNA is sealed by ligase III. There are approximately 10 different mammalian 
glycosylases, of which each is specific for a narrow range of lesions. Most, but not all, 
glycosylases have associated lyase activities, cleaving the DNA backbone between the 
phosphate and the sugar (at the 3’-carbon). 
 
6.3.2 Nucleotide excision repair (NER). 
Bulky DNA adducts and helix distortions are removed by NER. In NER, an 
oligonucleotide including the damaged base is removed by a multi-subunit 
exconuclease complex, followed by synthesis of new bases by DNA polymerase and 
sealing of the DNA strand by ligase 3. 
 
6.4 REPAIR OF 8-OXOGUANINE 
ESCODD estimated the background level of 8-oxoguanine in humans to approximately 
0.3-4.2 per million undamaged guanines. This poses a challenge for the enzymes that 
detect and remove this lesion. The mechanisms of action of these different enzymes are 
described shortly in section 6.4.1. hOgg1 is considered to be the main enzyme 
responsible for the removal of 8-oxoguanine in humans. hOgg1 removes 8-oxoguanine 
when it is paired with cytosine (figure 11). But even after replication has occurred, and 
8-oxoguanine has mispaired with adenine, the enzyme MUTYH (previously hMYH) 
can remove the wrongfully incorporated base (figure 11) 114. Removal of the mispaired 
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adenine allows replacement with cytosine by a specialised polymerase, subsequently 
giving hOgg1 a new chance to repair 8-oxoguanine (figure 11) 114. MutY, the bacterial 
parallel to MUTYH, has also been reported to remove adenine misincorporated 
opposite fapy-guanine, guanine and cytosine 45. In addition, the NER pathway can 
probably work as an alternative back-up pathway for removal of 8-oxoguanine 115. This 
has been observed in Ogg1 knock-out mice where, in the absence of Ogg1, NER 
functions as a back-up mechanism for removal of 8-oxoguanine 45. 8-oxoguanine has 
also been shown to be removed by the human glycosylase NEIL1, although 8-
oxoguanine is not its main substrate 116. In contrast to Ogg1, which works on double 
stranded DNA, NEIL1 seems to be particularly active on single stranded DNA and 
unpaired sequences in bubble DNA, i.e. on intermediates during replication and 
transcription 116. Another enzyme often mentioned in this context is MTH1, which 
degrades 8-oxodGTP from the nucleotide pool by hydrolysing it to 8-oxodGMP, 
thereby preventing possible misincorporation of damaged guanines into DNA 45. The 
bacterial parallels to hOgg1, MTH1 and MUTYH are called Fpg/MutM, MutT and 
MutY. 
 
Figure 11. Schematic description of the path from oxidation of guanine to the 
completed G-C to T-A transversion (illustrated by the pathway in the middle), and how 
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6.4.1 Glycosylases’ mechanism of action 
The glycosylase slides along the DNA chain. Frequently, it forms an ‘interrogation’ 
structure where bases flip out from the DNA helix and are inspected by the enzyme 
extra-helically. When encountering a damaged base, it is transferred from the 
interrogation complex to the enzyme’s active site 39. Bifunctional glycosylases, such as 
Ogg1 and Fpg, possess both glycosylase and AP-lyase activity, cleaving first the 
glycosidic bond between the base and the sugar and then the DNA backbone (at the 3’-
carbon of the abasic sugar) 40, 46. Fpg also have an attached AP-endonuclease activity 
cleaving the other phosphodiester bond at the DNA backbone (at the 5’-carbon of the 
abasic sugar) 46.  
 
6.4.2 The active site of hOgg1 
The BER process of 8-oxoguanine in humans is a multistep process, which is 
considered to be very lesion-specific. 8-oxoguanine is deeply inserted into the 
specificity pocket of hOgg1, and there is a range of interactions between the enzyme 
and 8-oxoguanine, with the phosphate moieties on the damaged DNA strand and the 
cytosine moiety on the complementary strand 49. David et al. highlights two 
interactions between Ogg1’s active site and 8-oxoguanine as particularly important for 
the recognition of 8-oxoguanine and rejection of guanine; a dipole-dipole interaction 
enabled by the local dipole opposite direction compared to guanine (as a result of the 
charge inversion at the 7’-nitrogen and the 8’-carbon), and a 8-oxoguanine-specific 
hydrogen bond between the hydrogen at the 7’-nitrogen and a glycin residue in Ogg1’s 
active site (Gly 42) 45.  
 
In contrast, Fpg, the bacterial parallel to hOgg1, has been shown to recognise a range of 
different DNA-lesions (see section 3.2.4). In spite of these two enzymes’ similar roles, 
they are not structurally related to each other 39. In fact, Ogg1’s structure is quite 
similar to that of AlkA 49.  
 
6.5 MEASURING DNA REPAIR 
The DNA repair has often been neglected in human biomonitoring studies, which in 
part is explained by the limitations of the available methods 52. Some of the drawbacks 
of ‘the challenge assays’ (where damage is induced and allowed to be repaired) are that 
they are laborious, demanding for example cell culturing or multiple sampling and that 
data might be difficult to interpret 52. It is not uncommon to measure expression of 
DNA repair genes, although mRNA levels often are found not to correlate with enzyme 
activity. Paz-Elizur et al. argue that an advantage of measuring enzymatic repair 
activity is that it includes the influence of genetic polymorphism, epigenetic effects, 
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transcription factors, splicing, RNA stability, translation factors, protein stability and 
possibly environmental and life style factors 117. Compared to the frequently measured 
mRNA levels or SNP analyses, it can be argued that assays estimating real DNA repair 
activity might provide more substantial information. DNA repair capacity can be 
assessed by extracting DNA repair enzymes from cells and measure the extract’s ability 
to repair DNA lesions. The efficiency of both BER and NER can be measured by 
modified versions of the comet assay 17-20, and the agent used to induce the damage 
defines the specificity of the assay 52. These relatively new applications of the comet 
assay are likely to receive growing attention in the future. Much remains to be done in 
the validation of these in vitro comet BER and NER assays. We have performed a 
validation study of the in vitro comet BER assay within ECVAG (study 3, section 4.2), 
where the reliability and reproducibility of the assay was investigated (Godschalk et al., 
in preparation). The preliminary findings indicate that six of eight laboratories could 
detect DNA repair incisions and that there was some consistency in the ranking of these 
samples although the reported levels varied substantially (Godschalk et al., in 
preparation). As with the comet assay, there is no standardised protocol for the in vitro 
comet BER assay. For example, different researchers a) use 10 or 20 min incubation 
with the extract containing repair enzymes, b) report outcome in different ways, and c) 
use different comet assay protocols. In addition, when an up-regulation of repair is 
observed, it is recommended to make sure that this is not in fact a direct damaging 
effect of the investigated compound or an induction of non-specific nucleases 118.  
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7 ANTIOXIDANTS 
An antioxidant is any substance, which delays or inhibits oxidative damage to a target 
molecule. Some antioxidants are supplied by the diet and others are endogenously 
synthesised, consisting of both enzymatic and non-enzymatic antioxidants. 
Antioxidants defend the body against oxidative injury and are widely assumed to 
provide a protection against various diseases. The diet has been estimated to account 
for 30-35% of the overall cancer risk. A balanced diet, rich in fruit and vegetables, 
contains a mixture of antioxidants, and is related to a reduction of cardiovascular 
diseases and cancer incidence 119, 120.  
 
Recent reports from the national health and nutrition examination survey (NHANES) 
document that 49% of the U.S. men, women and children and 54% of the adults 
included in the study between 2003-2006 consumed dietary supplements 121. 
Multivitamin supplements (≥3 vitamins, with or without minerals) were consumed by 
40% of the adults in the study 121. The use of dietary supplements has increased 
substantially over time since the first NHANES study in 1971-1974 121, 122. 
Supplements worth more than $20 billion/year are sold in the U.S. alone 123.  
 
Studies investigating the beneficial effects of antioxidant supplements, often containing 
a single or a few antioxidants in relatively high doses, have been inconclusive. The 
protective effects of antioxidant supplements containing for example β-carotene, 
vitamin A and vitamin E have been questioned 124. These results are likely to be 
explained, at least in part, by the fact that the protective effect of antioxidants is a 
combinatory effect of numerous antioxidants co-operating and that the delicate balance 
between antioxidants in the body might be disturbed by supplementing one or a few 
antioxidants in high doses. Antioxidants might even under certain conditions have pro-
oxidant effects 125, and antioxidants supplied by a balanced diet are preferred to dietary 
supplements, which contain a few antioxidants in high doses 119. However, whereas 
antioxidant supplementation to a mal-nutritious population could be of benefit, 
administration of supplements with antioxidants to individuals who are well nourished 
might lead to misleading conclusions.  
 
7.1 LARGE RANDOMISED CLINICAL INTERVENTION STUDIES WITH 
ANTIOXIDANTS 
In this section, a selection of the largest, randomised, placebo-controlled, double-blind 
antioxidant intervention studies with good design will be described and discussed. 
These include a) the Linxian general population trial, b) the α-tocopherol, β-carotene 
cancer prevention study (ATBC), c) the β-carotene and retinol efficacy trial (CARET), 
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d) the physicians’ health study, e) the supplémentation en vitamines et minéraux 
antioxydants (SU.VI.MAX) study, f) the women’s health initiative, and g) the selenium 
and vitamin E cancer prevention trial (SELECT). Three studies (studies b, d and g) had 
a 22 factorial design meaning that the subjects received one out of two antioxidants, 
both antioxidants, or placebo. Study a had a 24 factorial design, and in studies c, e and f 
the participants consumed either a multivitamin supplement or placebo.  
 
7.1.1 The Linxian general population trial  
The Linxian general population trial, which started in 1986 included 29,584 Chinese 
men and women aged 40-69 with a poor overall nutritional status, who consumed 
supplements with different combinations of vitamins and minerals or placebo daily for 
5.25 years 126-128. Significant reductions of total mortality (9%), total cancer mortality 
(13%) and stomach cancer mortality (21%) was observed in the participants that had 
received 30 mg α-tocopherol, 15 mg β-carotene and 50 µg selenium (as selenium 
yeast) 126. Significant beneficial effects of this treatment could still be seen in a 10-year 
follow up study, with a 5% reduction of total mortality (almost entirely due to effects in 
subjects younger than 55 years) and a 11% reduction of gastric cancer mortality 128. 
The other three combinations of antioxidants did not affect mortality 126. 
 
7.1.2 The ATBC study  
The ATBC study, which was initiated in 1985 included 29,133 Finish male smokers 
aged 50-69 years who consumed 20 mg β-carotene and/or 50 mg α-tocopherol or 
placebo daily for 5-8 years (median 6.1 years) 129-131. Significant increases of total 
mortality (8%), lung cancer incidence (16%) and non-significant increases of prostate 
cancer (23%) and stomach cancer (25%) were observed in the subjects who consumed 
β-carotene supplements 129, 131, 132. A significant 34% reduction of prostate cancer, a 
non-significant decrease of colorectal cancer (16%) and a non-significant increase of 
stomach cancer (25%) were observed in the subjects who consumed α-tocopherol 
supplements 129. Although the harm of the β-carotene supplement was not as evident a 
few years after the study had been terminated, a non-significant 17% increase of lung 
cancer incidence was seen during a 3-year follow up study, and a 7% significantly 
higher mortality was seen during a 8-year follow up study of the subjects that had 
received β-carotene 131.  
 
7.1.3 The CARET trial  
The CARET trial, which was initiated in 1983 (and was expanded in 1988 and 1991) 
included in total 18,314 U.S. male and female heavy smokers and former-smokers 
and/or male workers occupationally exposed to asbestos, aged 45-74, who consumed 
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30 mg β-carotene and 25,000 IU retinyl palmitate (vitamin A) or placebo daily for an 
average of 4 years 133-135. A significantly increased lung cancer risk of 28% was seen in 
supplemented subjects, including a 42% increased risk for smokers and a 40% 
increased risk for workers exposed to asbestos 135. In addition, a significantly increased 
all-cause-mortality of 17%, and a significantly increased lung cancer mortality of 46% 
was observed in the subjects who consumed supplements 135. After considering the 
outcome of the ATBC study and evaluating the effect of supplementation on mortality 
and cancer incidence, the CARET trial was terminated in January 1996, 21 months 
ahead of the planned end 133, 135. A harmful non-significant effect of treatment remained 
during a 6-year follow up study, including non-significant increases of all-cause 
mortality (8%), lung cancer mortality (20%) and lung cancer incidence (12%), with a 
more persistent effect seen in females than in males 133.  
 
7.1.4 The physicians’ health study I  
The physicians’ health study I, which was initiated in 1982, included 22,071 U.S. male 
physicians aged 40-84 who consumed 50 mg β-carotene every second day for 11.6-
14.2 years (average 12 years), and/or 325 mg aspirin every second day (although this 
administration was terminated already after 5 years) or placebo 136. Supplementation 
did not significantly influence any of the assessed parameters including all-cause 
mortality, cancer mortality and lung cancer incidence 136. No effect of β-carotene 
supplementation on lung cancer was seen among the 11% smokers or 39% former 
smokers in this study 136. 
 
7.1.5 The SU.VI.MAX study  
The SU.VI.MAX study, which was initiated in 1994 consisted of 13,017 French men 
and women aged 35-60 years who consumed either a multivitamin and mineral 
supplement consisting of 120 mg Vitamin C, 30 mg α-tocopherol, 6 mg β-carotene, 
100 µg selenium (as selenium yeast) and 20 mg zinc or placebo daily during 7.5 years 
(median) 137. The multivitamin supplement significantly decreased the risk of 
developing all types of cancer by 31% and all-cause mortality by 37% in men, but not 
in women 137. Among the men with a normal baseline level of prostate-specific antigen 
(PSA) that were supplemented with β-carotene, the incidence of prostate cancer was 
significantly decreased with 48% 138.  
 
7.1.6 The women’s health initiative  
The women’s health initiative was a 15-year research program initiated in 1991 that 
included 161,808 postmenopausal women and consisted of an observational study and 
several clinical trials. One of these trials included 36,282 U.S. postmenopausal women 
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aged 50-79 years who consumed 1 g of calcium (as calcium carbonate) and/or 400 IU 
of Vitamin D3 or placebo daily during 7 years (on average) 
139. Supplementation did not 
significantly affect the incidence of colorectal cancer, all types of cancer, all-cause 
mortality, total cancer mortality or colorectal cancer mortality 139. 
 
7.1.7 The SELECT trial  
The SELECT trial, which was initiated in 2001 consisted of 35,533 men from U.S., 
Canada and Puerto Rico aged >50 years who consumed 200 µg selenium (from L-
selenomethionine) and/or 400 IU α-tocopherol or placebo each day for 4.2-7.3 years 
(median 5.5 years) 140. The antioxidant supplement did not affect the incidence of 
prostate cancer, lung cancer, colorectal cancer, all types of cancer or all-cause mortality 
after 7 years, and therefore, the study, which was planned to continue for 12 years was 
terminated after 7 years 140. 
 
7.2 WHAT CAN WE LEARN FROM THESE STUDIES? 
Taken together, these large randomised clinical trials have not provided proof of a 
beneficial effect of antioxidant supplements. Instead, they raise questions regarding a) 
lifestyle, b) harm and benefit to different subgroups, c) appropriate doses, and d) types, 
forms and combinations of antioxidants.  
 
7.2.1 Smokers 
Results from the ATBC and CARET trials indicate that β-carotene supplementation 
increases smokers’ lung cancer risk 130, 134. However, it shall be emphasised that the 
participants in these studies consisted of heavy smokers that cannot be regarded to 
represent a healthy population. β-carotene supplementation were particularly harmful to 
the subjects who drank more and who smoked the most 132, 134. The participants in the 
ATBC study smoked on average 20.4 cigarettes per day and had smoked for an average 
of 35.9 years 130. Participants supplemented with β-carotene who smoked more than 20 
cigarettes/day had a significantly 25% increased risk of developing lung cancer, 
whereas those who smoked between 5-19 cigarettes/day had a non-significantly 3% 
decreased risk of developing lung cancer 132. In the CARET trial, a significant 28% 
increased risk of lung cancer was observed in supplemented subjects. Interestingly, in 
the subjects not exposed to asbestos, the effect was largest in current smokers, i.e. 
smokers at baseline, where a 42% increased lung cancer incidence was reported 134. On 
the other hand, supplementation did not affect the incidence of lung cancer in the 
former smokers not exposed to asbestos 134. The smokers and former smokers in the 
CARET trial were very heavy smokers or former smokers with at least 20, and an 
average of 49 pack-years of cigarette smoking 134. The asbestos-exposed workers had 
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been occupationally exposed to asbestos for an average of 27 years 134. In the 
physicians’ health study where 11% were smokers and 39% former smokers, smoking 
did not significantly increase or decrease the risk of lung cancer 136. However, the 
participants in the physicians’ health study had a relatively low risk of lung cancer 
(6.6% of the total cancer incidence) 136, 141.  
 
7.2.2 Poorly nourished individuals 
The Linxian study reported significant beneficial effects of supplementation for the 
participants that had received α-tocopherol, β-carotene and selenium 126. The 
participants in the Linxian general population trial is a high-risk population with 
regards to a very high incidence of oesophageal cancer and a poor overall nutritional 
status with low intake of several micronutrients, i.e. vitamins A, B2, C, E, selenium, 
zinc and calcium 142, 143. In the SU.VI.MAX study, supplementation with multivitamins 
significantly decreased the risk of developing all types of cancer and all-cause mortality 
in men, but not in women 137. This could be attributed to that the baseline intake of 
antioxidants was lower in men than in women 137.  
 
7.2.3 Healthy subjects 
In supplementation studies with healthy subjects, such as the physicians’ health study 
136, the women’s health initiative 139, the SELECT trial 140, and the women in the 
SU.VI.MAX study 137, no effects of antioxidant supplements on cancer incidence have 
been observed. 
 
There is some evidence that antioxidant supplements can be particularly harmful to 
certain subgroups. Factors that can affect the individual’s response to antioxidant 
supplementation include genetics, lifestyle, deficiency, diseases and pre-existing 
tumours 144. At a whole, the large intervention studies described in this chapter suggest 
that; a) supplementation with β-carotene can be harmful to smokers, and the risk seem 
to differ for former smokers, smokers, and heavy smokers, b) subjects with deficient or 
low intake of antioxidants can be particularly benefited by supplementation, and c) 




The dose of β-carotene is worth mentioning since the participants’ serum 
concentrations of β-carotene increased 17-fold and 12-fold in the ATBC study and the 
CARET trial, respectively 129, 135, whereas in the physicians’ health study I, the serum 
concentrations of β-carotene increased only 4-fold 136. Worth mentioning is also that a 
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lower dose of β-carotene was administered in the Linxian trial compared to the ATBC 
and CARET trials 127, 130, 134. 
 
7.2.5 Baseline values 
When looking closer at baseline serum levels of antioxidants and antioxidant intake in 
the studies described above, several interesting relationships with cancer incidence are 
observed. In the ATBC study, dietary intake and serum concentrations of β-carotene 
and α-tocopherol at baseline were inversely associated with lung cancer incidence in 
the control group 129. In the CARET trial, serum β-carotene concentrations at baseline 
were inversely associated with lung cancer incidence in both subjects supplemented 
with antioxidants and with placebo 135. In addition, consumption of fruit and cruciferae 
vegetables (e.g. broccoli) at baseline significantly protected against lung cancer in the 
placebo group (but not in the treatment group) 145. In SU.VI.MAX’s placebo group, the 
male quintile with the highest serum β-carotene concentrations at baseline had a 
significantly 45% decreased incidence of cancer compared to the lowest quintile 137. No 
such effect was seen for women 137. The investigators discuss that the significant effect 
seen in men, but not in women, could be related to that the men had both a relatively 
low antioxidant intake and lower baseline concentrations of antioxidants compared to 
women 137. In the women’s health initiative, serum 25-hydroxyvitamin D at baseline 
was significantly inversely associated with colorectal cancer, but baseline levels did not 
affect the outcome of the supplementation 139. In the physicians’ health study I, the men 
with the lowest quartile of plasma β-carotene levels at baseline, had a non-significant 
30% increased incidence of cancer compared to those in the highest quartile 141. The 
subjects with the lowest quartile of plasma β-carotene levels that were supplemented 
with β-carotene had a non-significant 17% decreased risk of cancer and a statistically 
significant 32% decreased risk of prostate cancer (which is the most frequent form of 
cancer in this group) 141. In a 15-year follow up study to the Linxian study, 
consumption of fresh fruit at baseline was shown to significantly protect against 
oesophageal squamous cell carcinoma and gastric cardia cancer but not against gastric 
non-cardia cancer 142.  
 
A reason often proposed for the discrepancies between observational studies and 
clinical intervention studies is that serum levels of certain antioxidants are biomarkers 
for a healthy diet, rich in fruits and vegetables, and that it is not individual antioxidants 
that are responsible for the beneficial effects. The antioxidant intake and serum levels at 
baseline, which can be expected to reflect a healthy diet, clearly are inversely related to 
cancer incidence in the studies described above. The results from the Linxian study, the 
physicians’ health study and the SU.VI.MAX study support the hypothesis that 
supplementation can be beneficial for poorly nourished individuals. Although, it is 
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possible that the dietary intake is a better marker for a long-time consumption than 
antioxidant supplements, and therefore has a larger impact on cancer, which develops 
gradually under a long period of time 144. Whether the beneficial effects are related to a 
balance between different micronutrients and minerals working together and/or 
beneficial effects of other food constituents, such as fibres, remains to be fully 
elucidated. 
 
7.3 ANTIOXIDANT INTERVENTION STUDIES AND THE COMET ASSAY 
Biomarkers both of exposure and biological effects are valuable tools when trying to 
elucidate the complex relationship between exposure and disease. In addition, studies 
using biomarkers are cheaper, faster and require fewer subjects than large intervention 
studies with disease and/or mortality as endpoints. An important area where biomarkers 
may serve as indicative measures, is within nutrition and its impact. This chapter 
contains a brief overview of the antioxidant intervention studies that have measured 
oxidative DNA lesions (but not DNA breaks) with the comet assay. A selection of 
intervention studies with antioxidant supplements is presented in the following section. 
Møller & Loft have in two review studies reported that antioxidant intervention studies 
with a weak design is more likely to show a protective effect against oxidative DNA 
damage 146, 147. The authors discuss that a randomised parallel placebo-controlled 
design is the optimal study design 146, and that a frequent problem is that studies lack 
power to detect small changes, i.e. that too few subjects have been used 146, 147. Only 
parallel randomised, placebo-controlled intervention studies with more than 10 
subjects, where antioxidants have been administered in multiple doses (ranging for 
weeks or months) are discussed in the following section. The subsequent section covers 
biomonitoring studies with nutritional modulation with food items containing fruits 
and/or vegetables. Only fruits and vegetable-related food items are discussed since 
these are most relevant to compare with the intervention study in paper IV. However, 
other food items (for example coffee) have also been shown to have protective effects. 
When supplementation is performed with food items, placebo-controlled intervention 
studies are often not feasible, and therefore studies where seasonal changes have been 
taken into account, i.e. randomised placebo-controlled parallel studies, and controlled 
studies with either parallel or cross-over design, are discussed. Again, only studies with 
more than 10 subjects, where the intervention has lasted for weeks/months are 
discussed. In addition, when assessed, information about DNA repair capacity and 
protection against DNA breaks induced ex vivo with H2O2, is provided for these studies 
in order to give a more complete picture.  
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7.3.1 Antioxidant supplements 
Healthy men and women who received either α- and β-carotene, lutein or lycopene for 
12 weeks had no significant differences in Fpg-sensitive sites or EndoIII-sensitive sites 
after intervention compared to subjects receiving placebo, in spite of significantly 
increased serum levels of the antioxidants 148. In another study, significantly decreased 
levels of EndoIII-sensitive sites was seen after a six weeks intervention with 500 mg 
rutin or placebo (in both treatment groups), although no significant differences were 
seen between the supplemented subjects and the subjects receiving placebo 149. In 
addition, supplementation did not provide any protection against H2O2-induced DNA 
breaks, nor did it affect urinary levels of MDA or 8-iso-PGF2α 
149. In a 24 day-
intervention with a multivitamin supplement roughly corresponding to the content 
found in 600 g of fruit and vegetables, no significant effect on Fpg-sensitive sites, 
EndoIII-sensitive sites or protection against H2O2-induced DNA breaks was observed 
in healthy non-smoking men and women 150. Also, BER capacity measured by the in 
vitro comet BER assay was unaffected by the intervention 151. However, in a study with 
poorly nourished smokers with relatively low plasma vitamin C levels and relatively 
high EndoIII- and Fpg-sensitive sites at baseline, consuming 500 mg slow release 
vitamin C and 182 mg plain release α-tocopherol during 4 weeks, significantly reduced 
levels of EndoIII-sensitive sites and Fpg-sensitive sites were seen after compared to 
before supplementation 151, 152. However, no significant differences were observed 
before and after supplementation in subjects receiving plain release vitamin C and α-
tocopherol or placebo 152. When investigating BER capacity using the in vitro comet 
BER assay, a significant increase of BER was observed after supplementation of slow 
release vitamin C and α-tocopherol for four weeks, whereas no effects by intervention 
were seen in the plain release vitamin C group or the placebo group 151. Healthy non-
smoking and smoking men who were supplemented with 100 mg vitamin C, 280 mg α-
tocopherol and 25 mg β-carotene daily for 20 weeks had significantly elevated plasma 
levels of all supplemented antioxidants and significantly decreased levels of EndoIII-
sensitive sites after supplementation compared to subjects receiving placebo 153.  
 
We have investigated the effect of consumption of antioxidant supplements consisting 
of extracts from fruit, berries and vegetables, in two randomised parallel double-blind 
placebo-controlled intervention studies with healthy middle-aged overweight men 154 
and type 2 diabetes subjects 155, respectively. The first study, which is included in this 
thesis (paper IV), is described thoroughly in chapter 8 154. In the second study, subjects 
with a high intake of fruits and vegetables and relatively well-controlled type 2 diabetes 
consumed antioxidant supplements or placebo daily for 12 weeks 155. Antioxidant 
supplementation did not affect the level of any of the measured biomarkers of oxidative 
stress, i.e. 8-iso-PGF2α in urine, plasma MDA, 8-oxodG/dG, Fpg-sensitive sites, plasma 
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nitrotyrosine or micronuclei (frequency of micronucleated transferring-positive 
reticulocytes), or inflammation, i.e. high sensitivity C-reactive protein (hs-CRP), 
interleukin 6 (IL-6) or 15-keto-dihydro-prostaglandin F2α, in spite of highly 
significantly (P < 0.001) elevated levels of serum/plasma levels of six out of seven 
measured antioxidants (γ-tocopherol, vitamin C, α-carotene, β-carotene, lycopene and 
lutein) 155. 
 
7.3.2 Nutritional modulation 
In a randomised placebo-controlled cross-over study, male smokers were supplemented 
with a vegetable burger (equivalent to ~500 g mixed fresh vegetables) and a fruit juice 
(consisting of juice concentrates of orange, blueberry, apple, lemon and lime) for three 
weeks, with a wash-out phase of two weeks between the treatment and placebo 156. In 
spite of highly significantly elevated serum levels of vitamin C and several carotenoids 
(α-carotene, β-carotene, β-cryptoxanthin and zeaxanthin), the antioxidant treatment did 
not affect the level of EndoIII-sensitive sites or the level of lipid peroxidation (MDA 
and 8-epi-prostaglandin F2α), nor did it protect against H2O2-induced DNA breaks 
156. 
Similarly, in a parallel dietary randomised placebo-controlled intervention study where 
healthy men and women consumed 600 g of fruits and vegetables, or a placebo tablet 
for 24 days, the supplementation did not significantly alter the level of Fpg-sensitive 
sites or EndoIII-sensitive sites, nor did it protect against H2O2-induced DNA breaks 
150. 
In a subsequent study of BER capacity using the in vitro comet BER assay (on the 
same subjects), no effect was observed by intervention 151. On the other hand, in a 
randomised study with cross-over design where healthy men and women consumed 1, 
2 or 3 green kiwifruits daily during three weeks supplementation periods, with two 
weeks wash-out periods between treatments, significantly lower levels of EndoIII- and 
Fpg-sensitive sites were observed after three weeks 157. Kiwifruit consumption induced 
an increased BER capacity as measured by the in vitro comet BER assay, and 
significantly protected against H2O2-induced DNA breaks 
157. In a recent similar 
randomised cross-over study, healthy men and women eating modest amount of fruits 
and vegetables consumed 1 or 2 golden kiwifruits during four weeks with four weeks 
wash-out periods between supplementations 158. Significantly decreased levels of both 
EndoIII- (after two kiwifruits/day) and Fpg-sensitive sites (after one kiwifruit/day) 
were observed after four weeks of supplementation 158. Kiwifruit consumption 
significantly protected against H2O2-induced DNA breaks, but neither BER nor NER 
were altered by supplementation as measured by the in vitro comet BER and NER 
assays 158. In a randomised parallel controlled intervention study healthy men and 
women drank 475-1000 ml (based on body weight) of blackcurrant juice (rich in 
anthocyanins and vitamin C), an anthocyanin drink, or a placebo drink daily during 
three weeks 159. No statistically significant effect on either EndoIII-sensitive sites or 
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Fpg-sensitive sites was observed between the supplemented subjects and the subjects 
consuming placebo 159. There was, however, an increased level of Fpg-sensitive sites 
after compared to before intervention in the subjects who consumed blackcurrant juice 
159. In a similar randomised parallel placebo-controlled intervention study where 
healthy women drank 750 ml cranberry juice or a placebo drink daily for two weeks, no 
effect was observed on EndoIII-sensitive sites nor was there any protection against 
H2O2-induced DNA breaks, in spite of a significant increase of vitamin C in plasma in 
the subjects drinking cranberry juice 160.  
 
In a controlled randomised cross-over study where male smokers and non-smokers 
consumed 200 g steamed broccoli or a control diet daily for 10 days with a 20 day 
wash-out period between the diets, the level of Fpg-sensitive sites decreased 
significantly after supplementation with broccoli, but when dividing the subjects into 
smokers and non-smokers, the decrease in Fpg-sensitive sites was only significant in 
the smokers 161. In addition, the broccoli supplementation significantly protected 
against H2O2-induced DNA breaks 
161. In a similar randomised cross-over study, male 
smokers consumed 250 g steamed broccoli or a control diet daily for 10 days with a 20 
day wash-out period between the diets 162. A significant protection against H2O2-
induced DNA breaks and significantly decreased levels of Fpg-sensitive sites was seen 
after consumption of broccoli but not after consumption of the control diet 162. BER 
capacity as measured by the in vitro comet BER assay was not altered by the 
intervention 162. In a recent large controlled randomised parallel intervention study (n = 
102), healthy male smokers consumed either a) a diet rich in antioxidants, b) three 
kiwifruits, or c) a controlled normal diet, daily during eight weeks 163. None of the 
interventions affected the levels of EndoIII- or Fpg-sensitive sites, nor did they protect 
against H2O2-induced DNA breaks 
163. A significantly increased BER capacity, and a 
significantly decreased NER capacity was observed after intervention in the subjects 
who consumed a diet rich in antioxidants as measured by the in vitro BER and NER 
comet assays 163. A significant decreased NER capacity, and a non-significant increased 
BER capacity was observed following supplementation with kiwifruit 163. 
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8 THE INTERVENTION STUDY WITH OVERWEIGHT 
MIDDLE-AGED MEN 
In a clinical placebo-controlled double-blind parallel intervention study, 60 overweight 
or obese (BMI 25-40) men, aged 36-66 years, were supplemented with a multivitamin-
multimineral supplement or placebo during six weeks (papers IV-V) 164. The subjects 
were randomly divided into a placebo group (n = 20), a single-dose group (n = 21) and 
a double-dose group (n = 19). Biomarkers of oxidative stress, metabolic variables and 
antioxidant levels in serum or plasma were assessed before and after treatment 154. The 
intervention study with all measured parameters are described in paper IV 154, whereas 
paper V is based on a potentially interesting observation from the intervention study 
that has also been further investigated in an in vitro cell study 164. 
  
8.1 THE ANTIOXIDANT SUPPLEMENT 
It was hypothesised that a range of antioxidants in doses resembling those achieved by 
a healthy diet would be more beneficial to health than the high doses of one or a few 
antioxidants that are frequently used in intervention studies with antioxidants 154. An 
antioxidant supplement, which consisted mainly of a combination of extracts derived 
from fruits, berries and vegetables, was developed by Dr. E. Rytter. The antioxidant 
contents of the supplements administered to the two dose groups are shown in Table 1. 
The content of antioxidants in the supplements described in paper V (Table II) was 
incorrect, and should have been multiplied by a factor 2 164. The antioxidant content in 
the supplements administered to the single-dose group approximately corresponded to 
the intake recommended by the Swedish national food administration (500 g of fruits, 
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Table 1. Characterisation of the antioxidant content administered to the two dose 




8.2 METHODS USED IN PAPER IV 
Several biomarkers for oxidative stress were measured both before and after 
supplementation of antioxidants or placebo. As biomarkers of oxidatively damaged 
DNA, Fpg-sensitive sites were measured by the comet assay 164 and the level of 8-
oxodG/106 dG was measured by HPLC-EC/UV 165. As biomarkers of lipid 
peroxidation, 8-isoprostaglandin F2α (8-iso-PGF2α) was measured by a 
radioimmunoassay 166 and malondialdehyde (MDA) was measured by HPLC with 
fluorescence detection 167. In addition, plasma or serum levels of eight different 
antioxidants as well as cholesterol and triacylglycerol concentrations were measured 
before and after antioxidant supplementation. 
 
8.2.1 Analysis of 8-oxodG with HPLC/EC/UV 
8-oxodG/106 dG was measured by the HPLC-EC/UV method as described by Hofer & 
Möller 165. On-line EC detection after separation with HPLC is a common method for 
analysis of 8-oxodG. 8-oxodG is oxidised in the electrochemical cell, which gives rise 
to a current that is proportional to the concentration of 8-oxodG. Non-damaged dG is 
measured by UV detection. The ratio between 8-oxodG and dG gives an estimate of the 
Ingredient Antioxidant
Green tea extract Catechins 160 mg 320 mg 
Bilberry extract Anthocyanidins 6 mg 12 mg 
Rosehip extract Ascorbic acid 90 mg 180 mg 
Acerola extract Ascorbic acid 30 mg 60 mg
Citrus extract Flavanones + Flavones 40 mg 80 mg 
Grape seed extract Proanthocyanidins 48 mg 96 mg
Cranberry extract Quinic acid 22 mg 44 mg 
Rutin        Rutin 60 mg 120 mg 
Vegetable oil concentrate α-tocopherol 20 mg 40 mg 
β-tocopherol 1.44 mg 2.88 mg 
γ-tocopherol 88 mg 176 mg 
δ-tocopherol 32 mg 64 mg 
Carrot extract α-carotene 4 mg 8 mg
β-carotene 8 mg 16 mg 
Tomato extract Lycopene 3 mg 6 mg 
Marigold extract Lutein 4 mg 8 mg 
Garlic oil not specified     
Thyme oil Thymol 120 µg 240 µg 
Carvacrol 8 µg 16 µg 
Artichoke extract Cynarin 3 mg 6 mg 
Selenium chelate and yeast Selenium 100 µg 200 µg 
Zinc sulphate Zinc 14 mg 28 mg
Content
Single dose group Double dose group
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level of oxidative stress. Artefact oxidation during the workup procedure of DNA has 
been shown to be responsible for overestimated levels of 8-oxodG (discussed in section 
4.1). An extensive effort to optimise and validate the 8-oxodG HPLC-EC/UV detection 
method has previously been done by Lennart Möller’s research group 62, 64, 168. In order 
to reduce oxidation during sample preparations, chilled centrifuges as well as high 
purity chemicals and enzymes were used, and workup was performed on ice. In 
addition, the antioxidant enzyme catalase from Aspergillus Niger and the electron 
acceptor 2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPO, a free radical) were used, and 
solutions were treated with chelex 100 resin to remove catalytic redox cycling 
transition metals 165, 168.  
 
8.2.2 Analysis of Fpg-sensitive sites with the comet assay 
Fpg-sensitive sites were measured by a low-alkaline version of the comet assay that is 
thoroughly described in paper V 164. The method is substantially different from the 
method employed by the author of this thesis (described in detail in paper III) 72. When 
comparing the two protocols, the method used in the intervention study with 
overweight middle-aged men is very time consuming, including a 1h wash after lysis, a 
1h incubation with enzyme buffer, a 30 min incubation with enzyme for penetration 
(cold), a 1 h incubation with enzyme at 37°C and two 45 min incubations in different 
alkaline buffers before electrophoresis. In addition, the units and composition of the 
lysis and alkaline solutions, differ and the alkaline unwinding and electrophoresis were 
performed at room temperature.  
 
8.2.3 Analysis of MDA 
Plasma MDA levels were measured by HPLC with fluorescence detection as described 
by Öhrvall et al. 167. MDA is the most commonly measured biomarker of lipid 
peroxidation. MDA is frequently incubated with thiobarbituric acid (TBA), with which 
it forms a fluorescing complex that can be measured. However, TBA binds to other 
substances as well, and the reaction is regarded to be unspecific. In order to minimise 
interference by other substances that bind to TBA, MDA-TBA adducts were separated 
from contaminants by HPLC and subsequently measured with fluorescence detection 
167. Although the reported levels of MDA were not exceedingly high, artefact oxidation 
during incubation of TBA with plasma cannot be excluded, since the incubation was 
performed at a high temperature (∼100°C) 169. A range of more specific methods to 
measure MDA levels have been developed since the intervention study in paper IV 
took place (in 2000) 169. 
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8.2.4 Analysis of 8-iso-PGF2α by a radioimmunoassay 
Another biomarker of lipid peroxidation, 8-iso-PGF2α in urine, was measured with a 
radioimmunoassay as described by Basu 166. 8-iso-PGF2α, is a prostaglandin derivative 
synthesised through free radical catalysed peroxidation of arachidonic acid, a 
polyunsaturated omega-6 fatty acid. In short, a known amount of 8-iso-PGF2α was 
made radioactive by labelling with tritium and the radioactive 8-iso-PGF2α was then 
mixed with an antibody specific for 8-iso-PGF2α (although it also possess certain cross-
reactivity to several compounds that is structurally related to 8-iso-PGF2α) 
166. When 
the sample is added to the mixture, the 8-iso-PGF2α from the sample competes with the 
radioactive 8-iso-PGF2α bound to the antibodies, leading to release of ‘free’ radioactive 
8-iso-PGF2α. By separation of the bound 8-iso-PGF2α from the radioactive ‘free’ 8-iso-
PGF2α, the latter could be determined using a β-liquid scintillation counter 
166. The 
level of variation of 8-iso-PGF2α in urine was corrected for by adjustment to the urinary 
creatinine concentration 154.  
 
It can be argued that 8-iso-PGF2α in urine is a more suitable biomarker than 8-iso-
PGF2α in plasma when assessing the effect of a dietary intervention (when expecting 
decreased levels), since the substance is more abundant in urine than in plasma 166.  
 
8.2.5 Analysis of antioxidants and metabolic variables 
Measurements of serum α- and γ-tocopherol, serum carotenoids (α-carotene, β-
carotene, lycopene and lutein), plasma selenium, plasma selenoprotein P, serum 
cholesterol and triacylglycerol concentrations were analysed by experienced 
investigators as described in paper IV 154.  
 
8.3 FINDINGS 
Highly significantly (P < 0.001) elevated levels of serum γ-tocopherol, serum α-
carotene, serum β-carotene, serum lycopene, serum lutein, plasma selenium and plasma 
selenoprotein P were observed in both dose groups compared to the placebo group after 
six weeks of intervention 154. In addition, the subjects that received the double-dose had 
significantly higher levels of serum γ-tocopherol, serum α-carotene, serum β-carotene, 
serum lycopene and plasma selenoprotein P, and non-significantly higher levels of 
plasma selenium and serum lutein, compared to subjects receiving the single-dose 154. 
The serum α-tocopherol concentration was not significantly altered by 
supplementation. In spite of the elevated levels of seven out of eight measured 
antioxidants, the intervention did not alter any of the four measured biomarkers for 
oxidative stress. In addition, no effect was seen on serum triacylglycerol, serum 
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cholesterol or BMI in any of the treatment groups after six weeks of antioxidant 
supplementation 154.  
 
Although the decrease of Fpg-sensitive sites in the double-dose group was not 
significant after compared to before intervention 154, the double-dose group had a 
significantly lower (P < 0.01) level of Fpg-sensitive sites compared to the control group 
after the intervention 164. The level of Fpg-sensitive sites after administration was 
significantly negatively correlated to the change in serum γ-tocopherol concentration (r 
= -0.30, n = 60, P = 0.018) 164.  
 
8.3.1 Season 
It can be argued that it is more relevant to compare the double-dose group with the 
control group after treatment since it has been observed that levels of DNA damage 
vary with season 170-173. In order to account for seasonal variations, a parallel study 
design is preferred to a sequential study design 174. A parallel design was used in the 
randomised placebo-controlled intervention study in papers IV and V, which was 
performed between April and June in year 2000. The subjects had been instructed to 
keep their food habits and level of physical activity stable during the study. However, it 
is likely that there was a change in exposure to sunlight during that period (spring-early 
summer), and an association between exposure to sunlight and DNA damage have been 
observed in several studies 171-173. It can be speculated that the small (non-significant) 
increase of Fpg-sensitive sites in the placebo-group was caused by exposure to sunlight, 
and that the significantly (11.7%) lower level of Fpg-sensitive sites in the double-dose 
group was due to a protective effect of the antioxidant supplement. Although the 
evidence of a protective effect of the antioxidant supplement can hardly be regarded as 
strong and the observed correlation between change of serum γ-tocopherol and Fpg-
sensitive sites was weak, it supported the hypothesis that γ-tocopherol could be an 
important protective agent against oxidative damage 164. The protective property of γ-
tocopherol was further studied in a cell study in paper IV (see section 8.3.5)164.  
 
8.3.2 The lack of correlation between different methods reflecting oxidative 
stress 
There was no correlation between any of the measured biomarkers of oxidative stress in 
paper IV. Since they all originate from oxidative damage, the complete lack of 
correlation is somewhat surprising. Discrepancies between different methods to assess 
DNA lesions or other methods of oxidative stress are however common. Although it 
cannot be excluded that a part of this is attributed to experimental variability, it is 
important to note that different agents cause different types and patterns of oxidative 
damage. In a summary of dietary intervention studies where comet assay have been 
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applied, Hoelzl et al. found that about half of the published studies found a protective 
effect against induced DNA damage and/or a decreased level of oxidatively damaged 
DNA 175. However, the overlap of positive results in 32 studies where DNA breaks, 
oxidatively damaged DNA (Fpg-sensitive sites, EndoIII-sensitive sites or both) and 
protection against induced DNA damage had been measured with the comet assay was 
poor, i.e. only 3 (10%) of the studies found a positive result in all parameters 175.  
 
Since 8-oxoguanine is Fpg’s main substrate, it might seem particularly strange that 
there is no correlation between 8-oxodG measured by HPLC-EC and Fpg-sensitive 
sites measured by the comet assay in paper IV. A similar lack of accordance between 
the level of Fpg-sensitive sites and 8-oxodG/dG was observed by ESCODD when 
comparing the two methods 67. There are several differences between the techniques 
that might explain these discrepancies. First, the HPLC-EC method is susceptible to 
artefact oxidation. The workup procedure in the HPLC techniques involves a relatively 
rough protocol, including about 8-10 centrifugation steps as well as purification and 
hydrolysis of DNA 81. Artefact oxidation is less critical for the comet assay since it 
requires only one or a few centrifugation steps and DNA is not purified 81, 176. 
ESCODD reported that the variation in background levels were higher when assessed 
by HPLC-EC compared to when assessed by comet assay (discussed in section 4.1). 
Secondly, although 8-oxoguanine is generally considered to be Fpg’s main substrate in 
vivo, the enzyme is not very specific, and in addition to 8-oxoguanine, it recognises a 
range of other lesions (see section 3.2.4). Actually, Fpg has even been suggested to 
recognise lesions resulting from alkylation damage 44. Due to its higher sensitivity, it 
can be argued that the comet assay is the preferred method when investigating 
background levels of damage in humans. It is possible that oxidatively damaged DNA 
is underestimated when assessed by the comet assay. Lesions in close proximity can 
appear as only one strand break and some positions of the lesions within the DNA 
might be less accessible to the enzyme 65, 177, 178. However, findings by Gedik et al. 
indicate that comet assay and HPLC-EC detects oxidative DNA lesions with similar 
efficiencies, which contradict an underestimation of damage with the comet assay 68.  
 
8.3.3 Duration, dose and subjects 
It cannot be excluded that either the duration and/or the dose of antioxidants were 
insufficient in the intervention study in paper IV. It is possible that the decrease of Fpg-
sensitive sites after antioxidant supplementation would have been significant if more 
subjects had been included in the study. Møller & Loft argue that the most likely effect 
of an antioxidant intervention study in healthy subjects would be less than a 10% 
difference in DNA lesions, and therefore, the number of subjects should be in the 
hundreds in order to get an appropriate power 147. However, 89% of the intervention 
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trials with antioxidants applying comet assay, published between 1996 and 2008, 
included ≤ 60 subjects 175. Similarly, the duration of the intervention study in paper IV 
is relatively long. Hoelzl et al. reported in 2009 that about 70% of the published 
antioxidant intervention studies applying comet assay lasted less than 4 weeks 175. 
 
8.3.4 Comparisons with other studies 
The absence of an effect on oxidative stress after antioxidant intervention observed in 
paper IV is supported by several intervention studies with comparable designs that all 
report null findings.  
 
Multivitamin supplements 
In a parallel placebo-controlled intervention study with antioxidant supplement roughly 
corresponding to the content found in 600 g of fruit and vegetables, Møller et al. found 
no significant effect on Fpg-sensitive sites or EndoIII-sensitive sites nor on protection 
against H2O2-induced DNA breaks in healthy men and women following a 24 day-
intervention 150. Also, we have performed another placebo-controlled randomised 
intervention study similar to the study in paper IV, in which subjects with type 2 
diabetes was supplemented with the same antioxidant supplement as in paper IV, albeit 
in a doubled dose, and for a doubled time (12 weeks) 155. Antioxidant supplementation 
did not affect the level of any of the six measured biomarkers of oxidative stress or 
inflammation, in spite of highly significantly elevated levels of serum/plasma levels of 
six out of seven measured antioxidants 155. As in the intervention study in paper IV, 
there was no significantly elevated level of α-tocopherol 155. 
 
Diets rich in antioxidants 
In a randomised placebo-controlled cross-over study, male smokers were supplemented 
with a vegetable and chicken burger and a fruit juice or a chicken burger and a placebo 
drink for 3 weeks 156. In spite of highly significantly elevated serum levels of vitamin C 
and several carotenoids, the antioxidant treatment did not affect the level of EndoIII-
sensitive sites or the level of lipid peroxidation (MDA and 8-epi-prostaglandin F2α) nor 
did it protect against H2O2-induced DNA breaks 
156. In a controlled intervention study 
where healthy men and women consumed 600 g of fruit and vegetables daily for 24 
days, the intervention did not significantly affect the levels of Fpg-sensitive sites or 
EndoIII-sensitive sites nor did it protect against H2O2-induced DNA breaks 
150. In a 
recent large controlled randomised parallel intervention study where healthy male 
smokers consumed a diet rich in antioxidants, i.e. a variety of different juices, berries, 
fruits, vegetables and nuts, or a controlled normal diet, daily during eight weeks, the 
intervention did not affect the levels of EndoIII- or Fpg-sensitive sites, nor did it protect 
against H2O2-induced DNA breaks 
163. 
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8.3.5 Vitamin E 
Vitamin E is a group of eight structurally related fat-soluble vitamins, four tocopherols 
(α, β, γ and δ) and four tocotrienols (α, β, γ and δ), acting as antioxidants by preventing 
the propagation of free radical reactions by donating hydrogen from their phenolic 
group to stabilise the radicals, and thereby break the chain of events leading to 
oxidative damage. The tocopherols protect the structure and function of human cell 
membranes 179. Vitamin E supplements often contain only α-tocopherol as for example 
in the SELECT, ATBC, SU.VI.MAX and the Linxian general population trials 
described in section 7.1. The reason for this is that the bioactivity and bioavailability of 
α-tocopherol is higher than that of γ-tocopherol and the other vitamin E compounds, 
and that α-tocopherol is more abundant in plasma than the other vitamin E compounds. 
However, the protective effect of oral supplementation of α-tocopherol has been 
questioned since supplementation with α-tocopherol has been demonstrated to decrease 
the level of the other vitamin E compounds, and several studies indicate that γ-
tocopherol, alone or in combination with α-tocopherol, was important in the protection 
against oxidative stress 180-182. Also, several studies indicate that γ-tocopherol has 
properties not shared by α-tocopherol 183-186. Chronic inflammation-related diseases are 
associated with an increased reactive nitrogen species (RNS) formation 187, which γ-
tocopherol is particularly efficient in removing 183, 184.  
 
Based on the interesting relationship observed between γ-tocopherol and Fpg-sensitive 
sites in the intervention study in paper IV, and on the questioned effect of 
supplementation with α-tocopherol 188, an in vitro cell study was performed to 
investigate the potential of γ-tocopherol and α-tocopherol to protect against induced 
DNA damage (paper V) 164. A549 cells that had been pre-incubated with α-tocopherol 
or γ-tocopherol for 23 h, were exposed to H2O2 or peroxynitrite (ONOO
-). After 1 h of 
incubation, the cells were analysed with the comet assay. γ-tocopherol protected against 
both H2O2- and ONOO
--induced oxidative DNA damage in a dose-dependent manner 
164. As little as 5 µM of γ-tocopherol significantly protected DNA against ONOO--
induced oxidative DNA damage 164. This is close to the levels found in plasma (3 µM) 
182. γ-tocopherol, as opposed to α-tocopherol, has an un-substituted 5’-carbon position 
on the chromanol ring available for reaction. It is possible that a part of the protective 
effect of γ-tocopherol against peroxynitrite in the in vitro cell study is explained by the 
formation of the stable adduct 5-nitro-γ-tocopherol 183-185. The lack of protection by α-
tocopherol was surprising. It is a weakness that RRR-α-tocopherol was not used instead 
of all-rac-α-tocopherol, which could be speculated to have a lower biopotency than the 
naturally occurring RRR-α-tocopherol. However, this is unlikely to explain the 
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complete lack of protective effect by α-tocopherol. When designing intervention 
studies, α-tocopherol’s potential to decrease the serum levels of the other potentially 
important vitamin E compounds should be considered.  
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9 CONCLUDING DISCUSSION  
9.1 COMET ASSAY 
Comet assay is a useful tool for biomonitoring studies and the advantages of it include; 
a) that a small cell sample is required, b) the possibility to measure damage in 
practically any cell type, c) the ability to measure heterogeneity in response within a 
cell population, and d) the relatively fast and economical procedure. When evaluating 
information obtained by comet assay the methodological procedures must be taken into 
account. Dušinská & Collins points out that the value of comet assay depends on how 
well it is learned and performed 174. The ECVAG trials indicate that the participants can 
detect dose-responses of both DNA breaks and Fpg-sensitive sites in coded cells, but 
that there is a large variation in the reported values 69, 70. Perhaps the largest surprise in 
the ECVAG studies was the large inter-laboratory variation in assessment of pre-made 
slides, indicating that a large fraction of the observed variation is attributed to 
differences in scoring 69. Although ECVAG study 2 (paper II) was not designed to 
investigate differences in protocols, several important parameters in the protocol were 
shown to significantly affect DNA migration 70. In paper III we verified that several 
protocol steps clearly affected the level of DNA migration in the comet assay, including 
a) agarose gel density, b) incubation time with Fpg, c) duration of alkaline treatment, 
and d) duration of electrophoresis, as well as the strength of the electric field applied 72. 
By adjusting the primary endpoints to standard curves, i.e. reference samples analysed 
with the same protocol, both the inter-laboratory differences 69, 70 and differences 
between protocols 72 could be decreased substantially, although not completely 
removed. A possible explanation to this is that the relative sensitivity towards alkaline 
treatment differs between samples that contain different amounts of ALS 72.  
 
With its multiple applications, comet assay is an important tool contributing to a 
detailed understanding of genotoxicity and individual susceptibility towards different 
exposures. However, there is certainly a need for further validation studies in order to 
reduce both assay variability and inter-laboratory variability. Although useful, comet 
assay will not reach its full potential until it has been fully validated.  
 
9.2 ANTIOXIDANTS 
It is clear that many intervention studies with antioxidants with good design report null 
findings. It is possible that healthy subjects cannot benefit from an intervention with 
antioxidants, as indicated by the large clinical placebo-controlled intervention studies in 
section 7.1. The scientific community has definitely started to question the antioxidant 
hypothesis, and Collins stated in 2009 that, at the very least, the antioxidant hypothesis 
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is an over-simplification 81. Halliwell recently discussed that antioxidant supplements 
rarely affect the overall level of oxidative damage and subsequently, it is not surprising 
that human intervention studies with disease or mortality as endpoints have failed to 
demonstrate the protective effect of antioxidants 2. Halliwell argues that the 
endogenously synthesised antioxidants, e.g. superoxide dismutase, peroxyredoxins and 
reduced glutathione, are far more important for cellular redox balance than the dietary 
antioxidants 2. A balanced situation allows some reactive species to perform important 
tasks, with as little oxidative damage as possible 2.  
 
It should be emphasised that an increased level of antioxidants following antioxidant 
supplementation, as observed by us in paper IV and in many other studies, is not a 
proof of a beneficial effect. If the supplemented antioxidants fail to modify the levels of 
oxidative damage to DNA and lipids, and large randomised placebo-controlled 
antioxidant supplementation studies fails to prevent disease (in healthy subjects), 
maybe it is time to start to re-evaluate the design of intervention studies. Lately, an 
interesting new approach is to try to estimate individual susceptibility in addition to 
estimating biomarkers of exposure. Measurement of repair capacity and 
polymorphisms in important enzymes provide new pieces to the puzzle and contribute 
to the understanding of the cellular redox balance. 
 
In an important review article about dietary antioxidants and oxidatively damaged 
DNA (in white blood cells and urine), Møller & Loft assigned intervention studies 
scores based on the quality of the design, ranging from 0 (weak design) to 3 (strong 
design) 147. 72 intervention studies had applied repeated dosing, but only 36 of these 
had a sufficiently good design to be eligible for a restricted analysis 147. Interestingly, 
when investigating all 72 intervention studies, and when investigating only the 36 
studies with a solid design and realistic baseline values, the same significant pattern 
was observed; the studies with best study design were significantly more likely to 
produce null results 147. Still, about half of the studies with solid design reported 
preventive effects of antioxidants supplementation, indicating that long-term 
antioxidant supplementation indeed reduces the levels of oxidative DNA lesions 147. 
However, the authors emphasise that the beneficial effect is weak 147.  
 
In a collaborative project performed by the World Cancer Research Fund and the 
American Institute for Cancer Research, an expert panel of some of the world’s leading 
scientists has performed a large systematic review of the literature aiming to provide 
recommendations to reduce the risk for cancer 119. The investigators concluded that 
dietary supplements are not recommended for cancer prevention and that it is preferred 
to achieve nutritional adequacy through the usual diet 119. However, dietary 
supplements may at times may be beneficial for specific groups, due to dietary 
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inadequacy or illness 119. Although there are obviously differences between antioxidant 
supplements, it is the author of this thesis’ opinion that it is much preferred to consume 
antioxidants via a balanced diet than by antioxidant supplements. Particular 
circumstances such as medication or deficiency can, however, justify the need for 
supplements. 
  72 
10 ACKNOWLEDGEMENTS 
From the bottom of my heart, I would like to thank all the people that have supported and 
helped me during the years I have worked with my thesis! 
Prof. Lennart Möller, my supervisor. Thank you very much for your support, enthusiasm, 
advice and encouragement! Aside from direct science, I would also like to thank you for the 
time you have spent teaching me how to hold speeches and lectures. Thank you for believing in 
me, frequently more than I have believed in myself! It has been a pleasure to be a part of your 
team during these years! Thank you very much for everything!  
Assoc. Prof. Peter Møller, my college in the ECVAG project. I think you are an extraordinary 
scientist and it has been a complete pleasure to work with you in the ECVAG projects! Thank 
you for everything!  
Dr. Elisabet Rytter, college in the ‘SPA’ projects. Thank you for all the hard work you have 
put into coordinating these studies, and for doing so with a never-ending enthusiasm and good 
mood! I’m very grateful that I was allowed to take part in these very interesting studies!  
All ECVAG collaborators: Thank you for good collaboration in the ECVAG projects! It has 
been a pleasure! In particular, Dr. Lykke Ali Forchhammer, my PhD student colleague, thank 
you for good collaboration and encouraging email correspondence, Prof. Andrew Collins, 
thank you for contributing with your comet assay expertise, and for the pleasant manner with 
which you answer all my questions, Prof. George (Don) Jones, thank you your enthusiasm, for 
good collaboration and for kindly supplying me with football tickets , and, Assoc. Prof. 
Roger Godschalk, thank you for good collaboration and enthusiasm. 
Other collaborators: Assoc. Prof. Britta Hylander-Rössner, Assoc. Prof. Ingegerd Odar-
Cederlöf, Prof. Ingela Fehrman-Ekholm and Dr. Royne Thorman, thank you for your 
support and for good collaboration! 
All my past and present friends and colleagues at AnTox: Dr. Hanna Karlsson, Dr. Eszter 
Nagy, Therese Bergström, Ylva Rodhe, Pontus Cronholm, Rikard Åsgård, Dr. Tim 
Hofer, Dr. Magnus Zeisig, Jingwen Shi, Johanna Kain, Jolanta Nowodzinska, Rebecca 
Uggla, Staffan Larsson and Mary-Ann Zetterqvist. Thank you for being such good friends 
and for all the nice moments around the coffee table! I’m truly blessed to have had the privilege 
to get to know you and to work side by side with you! Johanna Kain, thank you for all good 
scientific discussions in the office and for your support, it has meant a great deal to me! 
Jingwen Shi, thank you for always coming to work with a smile on your face, your enthusiasm 
is contagious. Pontus Cronholm, thank you for being such a warm-hearted person, always 
looking out for everyone’s well-being. Therese Bergström, thank you for being so organised 
and always helping me and reminding me about all administrative issues and for enthusiasm 
and good collaboration in the antioxidant projects. Ylva Rodhe, thank you for support and 
good collaboration in the salivary gland project, we made a good team. Dr. Magnus Zeisig, 
thank you for teaching me scientific English and how to turn on the Mac computer... Dr. Tim 
Hofer, thank you for being a devoted supervisor for my Master thesis project and for teaching 
me about the HPLC-EC/UV system. Staffan Larsson, thank you for supplying me with 
pictures to include in the thesis and for nice company. In particular, I would like to thank my 
very dear friends Dr. Hanna Karlsson and Dr. Eszter Nagy. Hanna, you are so incredibly 
talented, hard-working, kind and funny. I can’t wait to see what you will do next! The world is 
  73 
yours! Eszter, the multi-talent, there is nothing you couldn’t do! Thank you for letting me in 
into your beautiful world and for always making me laugh! Thank you also for proof-reading 
my thesis . Girls, it has been a complete pleasure to work side-by-side with you!  
KI-friends: Jari Taghavi, Kristin Stamyr, Dr. Azadeh Nakhai, Dr. Jenny Sjöberg, Dr. 
Karin Ljung Björklund, Susanna Kugelberg, Dr. Anna-Karin Lundbäck, Mohammed Ali 
and Dr. Erik Westman. Thank you for support, friendship, nice lunches and fun KI parties! 
My lovely friends: Malin Johansson, Erika Thurfjell, Edith Weitzel, Megha Huber, 
Miriam Zermouni, Sandra Nistell Stenberg, Jessica Enerstål, Matilda Nordqvist, Susanne 
Nilsson, Moa Lundqvist, Fia Berger, Linda Sjöblom, Johan Johansson, Tobias Björklund 
and the girls from the master’s education Eva, Sandra, Linda, Annika, Anna, Lina, and 
Marie-Louise. I’m incredibly lucky to have such good friends! Thank you all for your support 
during these years! 
Linda Fredriksson and Arne Johansson, my wonderful parents, thank you for your 
unconditional love and for everything that you have done for me! I’m so grateful for 
everything! When it comes to studies, I especially would like to acknowledge my mother, who 
has always encouraged further studies and who has not only been a teacher at work, but also at 
home by the kitchen table. This thesis is dedicated to you! 
Dr. Charlotte Johansson, my lovely sister and very dear friend, you are such a wonderful 
person and I’m so incredibly proud of you! I’m sure that you and your lovely boyfriend Dr. 
Ymir Saemundson’s talents and warm hearts will take you to many exciting places. Thank you 
both for everything! 
My family in law: Dr. Göran Ersson and Gabriella Ersson, my wonderful parents-in-law, I 
could not have gotten a more loving second family than yours! I’m so grateful for everything 
that you do for us! My sisters in law, Gylla Ersson von Wachenfelt and Hellvi Ersson and 
their families, thank you for being so lovely! To Torvald’s uncle and aunt, Dr. Laszlo Gereben 
and Irén Juhasz with families, thank you for welcoming me into the family in such a pleasant 
manner!   
The rest of my family: My uncle Lars Fredriksson and aunt Gunnel Johansson with families, 
my dear cousins Anette, Marcus and Sofia, and my wonderful god-children Saga, Vendela, 
Ester, Hjalmar and Edvin, who have a special place in my heart. Thank you! 
And last but not least, my wonderful husband Torvald Ersson, and the greatest joy of my life, 
my son, Vilgot. There are no words that can describe what you mean to me, and I am so 
incredibly grateful for both of you. I love you more than life! Thank you for everything, and for 
every day! 
 
The author of this thesis is a member of ECNIS (Environmental Cancer Risk, Nutrition and 
Individual Susceptibility), a network of excellence operating within the European Union 6
th
 
Framework Program, Priority 5: “Food Quality and Safety” (Contract No 513943), and 
ECVAG (the European Comet assay Validation Group) which was created within the ECNIS 
network of excellence in order to validate the comet assay.  
 
 
  74 
11 REFERENCES  
 
1. Djordjevic VB. Free radicals in cell biology. Int Rev Cytol, (2004) 237, 57-89. 
2. Halliwell B. Free radicals and antioxidants - quo vadis? Trends Pharmacol Sci, 
(2011) 32, 125-130. 
3. Halliwell B, Gutteridge J. Free Radicals in Biology and Medicine. 3rd ed. 
Oxford, Oxford University Press, 1999. 
4. Sies H. Oxidative stress II. Oxidants and Antioxidants. London, Academic 
Press, 1991. 
5. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the 
redox state of the glutathione disulfide/glutathione couple. Free Radic Biol 
Med, (2001) 30, 1191-1212. 
6. Kasai H, Nishimura S. Hydroxylation of Deoxyguanosine at the C-8 Position 
by Ascorbic-Acid and Other Reducing Agents. Nucleic Acids Res, (1984) 12, 
2137-2145. 
7. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: 
mechanisms, mutation, and disease. FASEB J, (2003) 17, 1195-1214. 
8. Møller P. The alkaline comet assay: towards validation in biomonitoring of 
DNA damaging exposures. Basic Clin Pharmacol Toxicol, (2006) 98, 336-345. 
9. Collins AR. The comet assay for DNA damage and repair: principles, 
applications, and limitations. Mol Biotechnol, (2004) 26, 249-261. 
10. Dušinská M, Collins A. Detection of oxidised purines and UV-induced 
photoproducts in DNA of single cells, by inclusion of lesion-specific enzymes 
in the comet assay. ATLA, (1996) 24, 405-411. 
11. Collins AR, Duthie SJ, Dobson VL. Direct enzymic detection of endogenous 
oxidative base damage in human lymphocyte DNA. Carcinogenesis, (1993) 14, 
1733-1735. 
12. Smith CC, O'Donovan MR, Martin EA. hOGG1 recognizes oxidative damage 
using the comet assay with greater specificity than FPG or ENDOIII. 
Mutagenesis, (2006) 21, 185-190. 
13. Collins AR, Dušinská M, Horska A. Detection of alkylation damage in human 
lymphocyte DNA with the comet assay. Acta Biochim Pol, (2001) 48, 611-614. 
14. Collins AR, Mitchell DL, Zunino A, deWit J, Busch D. UV-sensitive rodent 
mutant cell lines of complementation groups 6 and 8 differ phenotypically from 
their human counterparts. Environ Mol Mutagen, (1997) 29, 152-160. 
15. Gedik CM, Ewen SW, Collins AR. Single-cell gel electrophoresis applied to the 
analysis of UV-C damage and its repair in human cells. Int J Radiat Biol, 
(1992) 62, 313-320. 
16. Duthie SJ, McMillan P. Uracil misincorporation in human DNA detected using 
single cell gel electrophoresis. Carcinogenesis, (1997) 18, 1709-1714. 
17. Collins AR, Dušinská M, Horvathova E, Munro E, Savio M, Stetina R. Inter-
individual differences in repair of DNA base oxidation, measured in vitro with 
the comet assay. Mutagenesis, (2001) 16, 297-301. 
18. Langie SA, Knaapen AM, Brauers KJ, van Berlo D, van Schooten FJ, 
Godschalk RW. Development and validation of a modified comet assay to 
phenotypically assess nucleotide excision repair. Mutagenesis, (2006) 21, 153-
158.  
19. Gaivao I, Piasek A, Brevik A, Shaposhnikov S, Collins AR. Comet assay-based 
methods for measuring DNA repair in vitro; estimates of inter- and intra-
individual variation. Cell Biol Toxicol, (2009) 25, 45-52. 
  75 
20. Herrera M, Dominguez G, Garcia JM, Pena C, Jimenez C, Silva J, Garcia V, 
Gomez I, et al. Differences in repair of DNA cross-links between lymphocytes 
and epithelial tumor cells from colon cancer patients measured in vitro with the 
comet assay. Clin Cancer Res, (2009) 15, 5466-5472. 
21. Spanswick VJ, Hartley JM, Hartley JA. Measurement of DNA interstrand 
crosslinking in individual cells using the Single Cell Gel Electrophoresis 
(Comet) assay. Methods Mol Biol, (2010) 613, 267-282. 
22. Shaposhnikov S, Thomsen PD, Collins AR. Combining fluorescent in situ 
hybridization with the comet assay for targeted examination of DNA damage 
and repair. Methods Mol Biol, (2011) 682, 115-132. 
23. Tice R. The single cell gel/comet assay: A microgel electrophoretic technique 
for the detection of DNA damage and repair in individual cells. In: Phillips DH, 
Venitt S (Eds). Environmental Mutagenesis. Oxford, Bios Scientific Publishers, 
1995, Ch. 6, pp. 315–339. 
24. Kirkland D, Speit G. Evaluation of the ability of a battery of three in vitro 
genotoxicity tests to discriminate rodent carcinogens and non-carcinogens - III. 
Appropriate follow-up testing in vivo. Mutat Res, (2008) 654, 114-132. 
25. Sasaki YF, Sekihashi K, Izumiyama F, Nishidate E, Saga A, Ishida K, Tsuda S. 
The comet assay with multiple mouse organs: comparison of comet assay 
results and carcinogenicity with 208 chemicals selected from the IARC 
monographs and U.S. NTP Carcinogenicity Database. Crit Rev Toxicol, (2000) 
30, 629-799. 
26. Collins AR, Oscoz AA, Brunborg G, Gaivao I, Giovannelli L, Kruszewski M, 
Smith CC, Stetina R. The comet assay: topical issues. Mutagenesis, (2008) 23, 
143-151. 
27. Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, 
Natarajan AT, Norppa H, et al. IPCS guidelines for the monitoring of genotoxic 
effects of carcinogens in humans. Mutat Res, (2000) 463, 111-172. 
28. Collins AR. The use of bacterial repair endonucleases in the comet assay. 
Methods Mol Biol, (2011) 691, 137-147. 
29. Hartmann A, Agurell E, Beevers C, Brendler-Schwaab S, Burlinson B, Clay P, 
Collins A, Smith A, et al. Recommendations for conducting the in vivo alkaline 
Comet assay. 4th International Comet Assay Workshop. Mutagenesis, (2003) 
18, 45-51. 
30. Rojas E, Lopez MC, Valverde M. Single cell gel electrophoresis assay: 
methodology and applications. J Chromatogr B Biomed Sci Appl, (1999) 722, 
225-254. 
31. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, 
Miyamae Y, Rojas E, et al. Single cell gel/comet assay: guidelines for in vitro 
and in vivo genetic toxicology testing. Environ Mol Mutagen, (2000) 35, 206-
221. 
32. Östling O, Johanson KJ. Microelectrophoretic study of radiation-induced DNA 
damages in individual mammalian cells. Biochem Biophys Res Commun, (1984) 
123, 291-298. 
33. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for 
quantitation of low levels of DNA damage in individual cells. Exp Cell Res, 
(1988) 175, 184-191. 
34. Olive PL. Cell proliferation as a requirement for development of the contact 
effect in Chinese hamster V79 spheroids. Radiat Res, (1989) 117, 79-92. 
35. Olive PL, Banath JP, Durand RE. Detection of Etoposide Resistance by 
Measuring DNA Damage in Individual Chinese Hamster-Cells. J Natl Cancer 
Inst, (1990) 82, 779-783. 
  76 
36. Al-Salmani K, Abbas HH, Schulpen S, Karbaschi M, Abdalla I, Bowman KJ, 
So KK, Evans MD, et al. Simplified method for the collection, storage, and 
comet assay analysis of DNA damage in whole blood. Free Radic Biol Med, 
(2011) 51, 719-725. 
37. Shaposhnikov S, Azqueta A, Henriksson S, Meier S, Gaivao I, Huskisson NH, 
Smart A, Brunborg G, et al. Twelve-gel slide format optimised for comet assay 
and fluorescent in situ hybridisation. Toxicol Lett, (2010) 195, 31-34. 
38. Singh NP. Microgels for estimation of DNA strand breaks, DNA protein 
crosslinks and apoptosis. Mutat Res, (2000) 455, 111-127. 
39. Friedman JI, Stivers JT. Detection of damaged DNA bases by DNA glycosylase 
enzymes. Biochemistry, (2010) 49, 4957-4967. 
40. Stivers JT, Jiang YL. A mechanistic perspective on the chemistry of DNA 
repair glycosylases. Chemical Rev, (2003) 103, 2729-2759. 
41. Boiteux S, Gajewski E, Laval J, Dizdaroglu M. Substrate specificity of the 
Escherichia coli Fpg protein (formamidopyrimidine-DNA glycosylase): 
excision of purine lesions in DNA produced by ionizing radiation or 
photosensitization. Biochemistry, (1992) 31, 106-110. 
42. Tchou J, Bodepudi V, Shibutani S, Antoshechkin I, Miller J, Grollman AP, 
Johnson F. Substrate specificity of Fpg protein. Recognition and cleavage of 
oxidatively damaged DNA. J Biol Chem, (1994) 269, 15318-15324. 
43. David SS, Williams SD. Chemistry of Glycosylases and Endonucleases 
Involved in Base-Excision Repair. Chem Rev, (1998) 98, 1221-1262. 
44. Speit G, Schutz P, Bonzheim I, Trenz K, Hoffmann H. Sensitivity of the FPG 
protein towards alkylation damage in the comet assay. Toxicol Lett, (2004) 146, 
151-158. 
45. David SS, O'Shea VL, Kundu S. Base-excision repair of oxidative DNA 
damage. Nature, (2007) 447, 941-950. 
46. Hamm ML, Gill TJ, Nicolson SC, Summers MR. Substrate specificity of Fpg 
(MutM) and hOGG1, two repair glycosylases. J Am Chem Soc, (2007) 129, 
7724-7725. 
47. Hatahet Z, Kow YW, Purmal AA, Cunningham RP, Wallace SS. New 
substrates for old enzymes. 5-Hydroxy-2'-deoxycytidine and 5-hydroxy-2'-
deoxyuridine are substrates for Escherichia coli endonuclease III and 
formamidopyrimidine DNA N-glycosylase, while 5-hydroxy-2'-deoxyuridine is 
a substrate for uracil DNA N-glycosylase. J Biol Chem, (1994) 269, 18814-
18820. 
48. Boiteux S, Radicella JP. Base excision repair of 8-hydroxyguanine protects 
DNA from endogenous oxidative stress. Biochimie, (1999) 81, 59-67. 
49. Kuznetsov NA, Koval VV, Fedorova OS. Mechanism of recognition and repair 
of damaged DNA by human 8-oxoguanine DNA glycosylase hOGG1. 
Biochemistry (Mosc), (2011) 76, 118-130. 
50. O'Brien PJ, Ellenberger T. The Escherichia coli 3-methyladenine DNA 
glycosylase AlkA has a remarkably versatile active site. J Biol Chem, (2004) 
279, 26876-26884. 
51. Zharkov DO, Mechetin GV, Nevinsky GA. Uracil-DNA glycosylase: 
Structural, thermodynamic and kinetic aspects of lesion search and recognition. 
Mutat Res, (2010) 685, 11-20. 
52. Collins AR, Azqueta A. DNA repair as a biomarker in human biomonitoring 
studies; further applications of the comet assay. Mutat Res, (2011) 
doi:10.1016/j.mrfmmm.2011.03.005.   
  77 
53. Shaposhnikov SA, Salenko VB, Brunborg G, Nygren J, Collins AR. Single-cell 
gel electrophoresis (the comet assay): Loops or fragments? Electrophoresis, 
(2008) 29, 3005-3012. 
54. Azqueta A, Meier S, Priestley C, Gutzkow KB, Brunborg G, Sallette J, 
Soussaline F, Collins A. The influence of scoring method on variability in 
results obtained with the comet assay. Mutagenesis, (2011) 26, 393-399.  
55. Horvathova E, Dušinská M, Shaposhnikov S, Collins AR. DNA damage and 
repair measured in different genomic regions using the comet assay with 
fluorescent in situ hybridization. Mutagenesis, (2004) 19, 269-276. 
56. Santos SJ, Singh NP, Natarajan AT. Fluorescence in situ hybridization with 
comets. Exp Cell Res, (1997) 232, 407-411. 
57. Pfuhler S, Wolf HU. Detection of DNA-crosslinking agents with the alkaline 
comet assay. Environ Mol Mutagen, (1996) 27, 196-201. 
58. Dušinská M, Collins AR. The comet assay in human biomonitoring: gene-
environment interactions. Mutagenesis, (2008) 23, 191-205. 
59. Rothman N, Stewart WF, Rabkin CS, Schulte PA. The development, validation, 
and application of biomarkers for early biologic effects. In: Mendelsohn ML, 
Peeters JP, Normandy MJ (Eds). Biomarkers and Occupational Health: 
Progress and Perspectives. Washington DC, Joseph Henry Press, 1995, pp. 
109–115. 
60. Collins A, Cadet J, Epe B, Gedik C. Problems in the measurement of 8-
oxoguanine in human DNA. Report of a workshop, DNA Oxidation, held in 
Aberdeen, UK, 19-21 January, 1997. Carcinogenesis, (1997) 18, 1833-1836. 
61. Lunec J. ESCODD: European Standards Committee on Oxidative DNA 
damage. Free Radic Res, (1998) 29, 601-608. 
62. ESCODD. Comparison of different methods of measuring 8-oxoguanine as a 
marker of oxidative DNA damage. ESCODD (European Standards Committee 
on Oxidative DNA Damage). Free Radic Res, (2000) 32, 333-341. 
63. Riis B. Comparison of results from different laboratories in measuring 8-oxo-2'-
deoxyguanosine in synthetic oligonucleotides. Free Radic Res, (2002) 36, 649-
659. 
64. ESCODD. Inter-laboratory validation of procedures for measuring 8-oxo-7,8-
dihydroguanine/8-oxo-7,8-dihydro-2'-deoxyguanosine in DNA. Free Radic 
Res, (2002) 36, 239-245. 
65. ESCODD. Comparative analysis of baseline 8-oxo-7,8-dihydroguanine in 
mammalian cell DNA, by different methods in different laboratories: an 
approach to consensus. Carcinogenesis, (2002) 23, 2129-2133. 
66. ESCODD. Measurement of DNA oxidation in human cells by chromatographic 
and enzymic methods. Free Radic Biol Med, (2003) 34, 1089-1099. 
67. Gedik CM, Collins A; ESCODD. Establishing the background level of base 
oxidation in human lymphocyte DNA: results of an interlaboratory validation 
study. FASEB J, (2005) 19, 82-84.  
68. Gedik CM, Boyle SP, Wood SG, Vaughan NJ, Collins AR. Oxidative stress in 
humans: validation of biomarkers of DNA damage. Carcinogenesis, (2002) 23, 
1441-1446. 
69. Forchhammer L, Johansson C, Loft S, Möller L, Godschalk RW, Langie SA, 
Jones GD, Kwok RW, et al. Variation in the measurement of DNA damage by 
comet assay measured by the ECVAG inter-laboratory validation trial. 
Mutagenesis, (2010) 25, 113-123. 
70. Johansson C, Møller P, Forchhammer L, Loft S, Godschalk RW, Langie SA, 
Lumeij S, Jones GD, et al. An ECVAG trial on assessment of oxidative damage 
to DNA measured by the comet assay. Mutagenesis, (2010) 25, 125-132. 
  78 
71. Zainol M, Stoute J, Almeida GM, Rapp A, Bowman KJ, Jones GDD, ECVAG. 
Introducing a true internal standard for the Comet assay to minimize intra- and 
inter-experiment variability in measures of DNA damage and repair. Nucleic 
Acids Res, (2009) 37, e150. 
72. Ersson C, Möller L. The effects on DNA migration of altering parameters in the 
comet assay protocol such as agarose density, electrophoresis conditions, and 
durations of the enzyme or the alkaline treatments. Mutagenesis, (2011) doi: 
10.1093/mutage/ger034. 
73. Speit G, Trenz K, Schutz P, Rothfuss A, Merk O. The influence of temperature 
during alkaline treatment and electrophoresis on results obtained with the comet 
assay. Toxicol Lett, (1999) 110, 73-78. 
74. Azqueta A, Gutzkow KB, Brunborg G, Collins AR. Towards a more reliable 
comet assay: Optimising agarose concentration, unwinding time and 
electrophoresis conditions. Mutat Res, (2011) 724, 41-45. 
75. Bauch T, Böcker W, Mallek U, Müller WU, Streffer C. Optimization and 
standardization of the "comet assay" for analyzing the repair of DNA damage in 
cells. Strahlenther Onkol, (1999) 175, 333-340. 
76. Available from NewGeneris homepage [online]: http://www.newgeneris.org/ 
[16 June 2011]. 
77. Azqueta A, Shaposhnikov S, Collins AR. DNA oxidation: Investigating its key 
role in environmental mutagenesis with the comet assay. Mutat Res, (2009) 
674, 101-108. 
78. Kohn KW. Principles and practice of DNA filter elution. Pharmacol Ther, 
(1991) 49, 55-77. 
79. Forchhammer L, Bräuner EV, Folkmann JK, Danielsen PH, Nielsen C, Jensen 
A, Loft S, Friis G, Møller P. Variation in assessment of oxidatively damaged 
DNA in mononuclear blood cells by the comet assay with visual scoring. 
Mutagenesis, (2008) 23, 223-231. 
80. Vijayalaxmi, Tice RR, Strauss GHS. Assessment of radiation-induced DNA 
damage in human blood lymphocytes using the single-cell gel electrophoresis 
technique. Mutat Res, (1992) 271, 243-252. 
81. Collins AR. Investigating oxidative DNA damage and its repair using the comet 
assay. Mutat Res, (2009) 681, 24-32. 
82. Will O, Gocke E, Eckert I, Schulz I, Pflaum M, Mahler HC, Epe B. Oxidative 
DNA damage and mutations induced by a polar photosensitizer, Ro19-8022. 
Mutat Res, (1999) 435, 89-101. 
83. Speit G, Hartmann A. The comet assay: a sensitive genotoxicity test for the 
detection of DNA damage and repair. Methods Mol Biol, (2006) 314, 275-286. 
84. Collins AR, Dušinská M. Oxidation of cellular DNA measured with the comet 
assay. Methods Mol Biol, (2002) 186, 147-159. 
85. Available from COMICS homepage [online]: 
http://comics.vitamib.com/electrophoresis-physics [15 June 2011]. 
86. Collins A, Dušinská M, Franklin M, Somorovska M, Petrovska H, Duthie S, 
Fillion L, Panayiotidis M, et al. Comet assay in human biomonitoring studies: 
reliability, validation, and applications. Environ Mol Mutagen, (1997) 30, 139-
146. 
87. Garcia O, Mandina T, Lamadrid AI, Diaz A, Remigio A, Gonzalez Y, Piloto J, 
Gonzalez JE, et al. Sensitivity and variability of visual scoring in the comet 
assay. Results of an inter-laboratory scoring exercise with the use of silver 
staining. Mutat Res, (2004) 556, 25-34. 
88. Møller P, Friis G, Christensen PH, Risom L, Plesner G, Kjaersgaard J, Vinzents 
P, Loft S, et al. Intra-laboratory comet assay sample scoring exercise for 
  79 
determination of formamidopyrimidine DNA glycosylase sites in human 
mononuclear blood cell DNA. Free Radic Res, (2004) 38, 1207-1214. 
89. Tice RR, Strauss GH. The single cell gel electrophoresis/comet assay: a 
potential tool for detecting radiation-induced DNA damage in humans. Stem 
Cells, (1995) 13, Suppl 1, 207-214. 
90. Hellman B, Vaghef H, Boström B. The concepts of tail moment and tail inertia 
in the single cell gel electrophoresis assay. Mutat Res, (1995) 336, 123-131. 
91. Olive PL, Banath JP. Induction and rejoining of radiation-induced DNA single-
strand breaks: "tail moment" as a function of position in the cell cycle. Mutat 
Res, (1993) 294, 275-283. 
92. Karlsson HL, Nygren J, Möller L. Genotoxicity of airborne particulate matter: 
the role of cell-particle interaction and of substances with adduct-forming and 
oxidizing capacity. Mutat Res, (2004) 565, 1-10. 
93. Olive PL. The comet assay. An overview of techniques. Methods Mol Biol, 
(2002) 203, 179-194. 
94. Collins AR, Dušinská M, Gedik CM, Stetina R. Oxidative damage to DNA: do 
we have a reliable biomarker? Environ Health Perspect, (1996) 104 Suppl 3, 
465-469. 
95. Kohn KW, Erickson LC, Ewig RA, Friedman CA. Fractionation of DNA from 
mammalian cells by alkaline elution. Biochemistry, (1976) 15, 4629-4637. 
96. Ahnström G, Erixon K. In: Friedberg EC, Hanawalt PC (Eds). DNA Repair: A 
Laboratory Manual of Research Procedures. New York, Marcel Dekker, 1981, 
pp. 403−418  
97. Malyapa RS, Bi C, Ahern EW, Roti Roti JL. Detection of DNA damage by the 
alkaline comet assay after exposure to low-dose gamma radiation. Radiat Res, 
(1998) 149, 396-400. 
98. Pflaum M, Will O, Epe B. Determination of steady-state levels of oxidative 
DNA base modifications in mammalian cells by means of repair endonucleases. 
Carcinogenesis, (1997) 18, 2225-2231. 
99. Ersson C, Thorman R, Rodhe Y, Möller L, Hylander B. DNA damage in 
salivary gland tissue in patients with chronic kidney disease, measured by the 
comet assay. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, (2011) 112, 
209-215. 
100. Karlsson HL. The comet assay in nanotoxicology research. Anal Bioanal Chem, 
(2010) 398, 651-666. 
101. Stone V, Johnston H, Schins RPF. Development of in vitro systems for 
nanotoxicology: methodological considerations. Crit Rev Toxicol, (2009) 39, 
613-626. 
102. Asmuss M, Mullenders LHF, Eker A, Hartwig A. Differential effects of toxic 
metal compounds on the activities of Fpg and XPA, two zinc finger proteins 
involved in DNA repair. Carcinogenesis, (2000) 21, 2097-2104. 
103. Hirano T. Repair system of 7,8-dihydro-8-oxoguanine as a defense line against 
carcinogenesis. J Radiat Res (Tokyo), (2008) 49, 329-340. 
104. Halliwell B. Establishing the significance and optimal intake of dietary 
antioxidants: the biomarker concept. Nutr Rev, (1999) 57, 104-113. 
105. DeMarini DM. Genotoxicity of tobacco smoke and tobacco smoke condensate: 
a review. Mutat Res, (2004) 567, 447-474. 
106. Bonassi S, Norppa H, Ceppi M, Strömberg U, Vermeulen R, Znaor A, 
Cebulska-Wasilewska A, Fabianova E, et al. Chromosomal aberration 
frequency in lymphocytes predicts the risk of cancer: results from a pooled 
cohort study of 22 358 subjects in 11 countries. Carcinogenesis, (2008) 29, 
1178-1183. 
  80 
107. Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, Kirsch-Volders 
M, Zeiger E, et al. An increased micronucleus frequency in peripheral blood 
lymphocytes predicts the risk of cancer in humans. Carcinogenesis, (2007) 28, 
625-631. 
108. Hagmar L, Bonassi S, Strömberg U, Brøgger A, Knudsen LE, Norppa H, 
Reuterwall C. Chromosomal aberrations in lymphocytes predict human cancer: 
A report from the European study group on cytogenetic biomarkers and health 
(ESCH). Cancer Res, (1998) 58, 4117-4121. 
109. Neeley WL, Essigmann JM. Mechanisms of formation, genotoxicity, and 
mutation of guanine oxidation products. Chem Res Toxicol, (2006) 19, 491-505. 
110. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-
deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. 
Mutat Res, (1997) 387, 147-163. 
111. Pouget JP, Douki T, Richard MJ, Cadet J. DNA damage induced in cells by 
gamma and UVA radiation as measured by HPLC/GC-MS and HPLC-EC and 
Comet assay. Chem Res Toxicol, (2000) 13, 541-549. 
112. Hsu GW, Ober M, Carell T, Beese LS. Error-prone replication of oxidatively 
damaged DNA by a high-fidelity DNA polymerase. Nature, (2004) 431, 217-
221. 
113. Moriya M, Ou C, Bodepudi V, Johnson F, Takeshita M, Grollman AP. Site-
specific mutagenesis using a gapped duplex vector: a study of translesion 
synthesis past 8-oxodeoxyguanosine in E. coli. Mutat Res, (1991) 254, 281-288. 
114. Kirouac KN, Ling H. Unique active site promotes error-free replication 
opposite an 8-oxo-guanine lesion by human DNA polymerase iota. Proc Natl 
Acad Sci U S A, (2011) 108, 3210-3215. 
115. Reardon JT, Bessho T, Kung HC, Bolton PH, Sancar A. In vitro repair of 
oxidative DNA damage by human nucleotide excision repair system: Possible 
explanation for neurodegeneration in Xeroderma pigmentosum patients. Proc 
Natl Acad Sci U S A, (1997) 94, 9463-9468. 
116. Hazra TK, Das A, Das S, Choudhury S, Kow YW, Roy R. Oxidative DNA 
damage repair in mammalian cells: A new perspective. DNA Repair (Amst), 
(2007) 6, 470-480. 
117. Paz-Elizur T, Sevilya Z, Leitner-Dagan Y, Elinger D, Roisman LC, Livneh Z. 
DNA repair of oxidative DNA damage in human carcinogenesis: Potential 
application for cancer risk assessment and prevention. Cancer Lett, (2008) 266, 
60-72. 
118. Azqueta A, Lorenzo Y, Collins AR. In vitro comet assay for DNA repair: a 
warning concerning application to cultured cells. Mutagenesis, (2009) 24, 379-
381. 
119. World Cancer Research Fund/American Institute for Cancer Research. Food, 
Nutrition, and Physical Activity, and the Prevention of Cancer: A Global 
Perspective. Washington DC, AICR, 2007. 
120. Ness AR, Powles JW. Fruit and vegetables, and cardiovascular disease: a 
review. Int J Epidemiol, (1997) 26, 1-13. 
121. Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, Betz JM, 
Sempos CT, Picciano MF. Dietary supplement use in the United States, 2003-
2006. J Nutr, (2011) 141, 261-266. 
122. Gahche J, Bailey R, Burt V, Hughes J, Yetley E, Dwyer J, Picciano MF, 
McDowell M, et al. Dietary supplement use among U.S. adults has increased 
since NHANES III (1988-1994). NCHS Data Brief, (2011), 1-8. 
  81 
123. National Institutes of Health State-of-the-Science Conference statement: 
multivitamin/mineral supplements and chronic disease prevention. Ann Intern 
Med. (2006) 145, 364-371. 
124. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in 
randomized trials of antioxidant supplements for primary and secondary 
prevention: systematic review and meta-analysis. JAMA, (2007) 297, 842-857. 
125. Halliwell B. The antioxidant paradox. Lancet, (2000) 355, 1179-1180. 
126. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, Yang CS, Zheng SF, 
et al. Nutrition intervention trials in Linxian, China: supplementation with 
specific vitamin/mineral combinations, cancer incidence, and disease-specific 
mortality in the general population. J Natl Cancer Inst, (1993) 85, 1483-1492. 
127. Blot WJ, Li JY, Taylor PR, Guo WD, Dawsey SM, Li B. The Linxian trials: 
Mortality rates by vitamin-mineral intervention group. Am J Clin Nutr, (1995) 
62, S1424-S1426. 
128. Qiao YL, Dawsey SM, Kamangar F, Fan JH, Abnet CC, Sun XD, Johnson LL, 
Gail MH, et al. Total and cancer mortality after supplementation with vitamins 
and minerals: Follow-up of the Linxian General Population Nutrition 
Intervention Trial. J Natl Cancer Inst, (2009) 101, 507-518. 
129. Albanes D, Heinonen OP, Huttunen JK, Taylor PR, Virtamo J, Edwards BK, 
Haapakoski J, Rautalahti M, et al. Effects of alpha-tocopherol and beta-carotene 
supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene 
Cancer Prevention Study. Am J Clin Nutr, (1995) 62, S1427-S1430. 
130. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The 
effect of vitamin E and beta-carotene on the incidence of lung cancer and other 
cancers in male smokers. N Engl J Med, (1994) 330, 1029-1035. 
131. Virtamo J, Pietinen P, Huttunen JK, Malila N, Virtanen MJ, Albanes D, Taylor 
PR, Albert P. Incidence of cancer and mortality following alpha-tocopherol and 
beta-carotene supplementation: A postintervention follow-up. JAMA, (2003) 
290, 476-485. 
132. Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, 
Hartman AM, Palmgren J, et al. Alpha-tocopherol and beta-carotene 
supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene 
cancer prevention study: effects of base-line characteristics and study 
compliance. J Natl Cancer Inst, (1996) 88, 1560-1570. 
133. Goodman GE, Thornquist MD, Balmes J, Cullen MR, Meyskens FL, Omenn 
GS, Valanis B, Williams JH. The beta-carotene and retinol efficacy trial: 
Incidence of lung cancer and cardiovascular disease mortality during 6-year 
follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer 
Inst, (2004) 96, 1743-1750. 
134. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, 
Keogh JP, Meyskens FL, et al. Risk factors for lung cancer and for intervention 
effects in CARET, the beta-carotene and retinol efficacy trial. J Natl Cancer 
Inst, (1996) 88, 1550-1559. 
135. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, 
Keogh JP, Meyskens FL, et al. Effects of a combination of beta carotene and 
vitamin A on lung cancer and cardiovascular disease. N Engl J Med, (1996) 
334, 1150-1155. 
136. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, 
Belanger C, LaMotte F, et al. Lack of effect of long-term supplementation with 
beta carotene on the incidence of malignant neoplasms and cardiovascular 
disease. N Engl J Med, (1996) 334, 1145-1149. 
  82 
137. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, 
Favier A, Briancon S. The SU.VI.MAX Study: a randomized, placebo-
controlled trial of the health effects of antioxidant vitamins and minerals. Arch 
Intern Med, (2004) 164, 2335-2342. 
138. Meyer F, Galan P, Douville P, Bairati I, Kegle P, Bertrais S, Estaquio C, 
Hercberg S. Antioxidant vitamin and mineral supplementation and prostate 
cancer prevention in the SU.VI.MAX trial. Int J Cancer, (2005) 116, 182-186. 
139. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, 
O'Sullivan MJ, Margolis KL, Ockene JK, et al. Calcium plus vitamin D 
supplementation and the risk of colorectal cancer. N Engl J Med, (2006) 354, 
684-696. 
140. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, 
Parnes HL, Minasian LM, et al. Effect of selenium and vitamin E on risk of 
prostate cancer and other cancers: the Selenium and Vitamin E Cancer 
Prevention Trial (SELECT). JAMA, (2009) 301, 39-51. 
141. Cook NR, Stampfer MJ, Ma J, Manson JE, Sacks FM, Buring JE, Hennekens 
CH. Beta-carotene supplementation for patients with low baseline levels and 
decreased risks of total and prostate carcinoma. Cancer, (1999) 86, 1783-1792. 
142. Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW, Mark SD, Qiao 
YL, Taylor PR. Prospective study of risk factors for esophageal and gastric 
cancers in the Linxian General Population Trial cohort in China. Int J Cancer, 
(2005) 113, 456-463. 
143. Zou XN, Taylor PR, Mark SD, Chao A, Wang W, Dawsey SM, Wu YP, Qiao 
YL, et al. Seasonal variation of food consumption and selected nutrient 
intake,in Linxian, a high risk area for esophageal cancer in China. Int J Vitam 
Nutr Res, (2002) 72, 375-382. 
144. Greenwald P, Anderson D, Nelson SA, Taylor PR. Clinical trials of vitamin and 
mineral supplements for cancer prevention. Am J Clin Nutr, (2007) 85, 314S-
317S. 
145. Neuhouser ML, Patterson RE, Thornquist MD, Omenn GS, King IB, Goodman 
GE. Fruits and vegetables are associated with lower lung cancer risk only in the 
placebo arm of the beta-carotene and retinol efficacy trial (CARET). Cancer 
Epidemiol Biomarkers Prev, (2003) 12, 350-358. 
146. Møller P, Loft S. Oxidative DNA damage in human white blood cells in dietary 
antioxidant intervention studies. Am J Clin Nutr, (2002) 76, 303-310. 
147. Møller P, Loft S. Dietary antioxidants and beneficial effect on oxidatively 
damaged DNA. Free Radic Biol Med, (2006) 41, 388-415.  
148. Collins AR, Olmedilla B, Southon S, Granado F, Duthie SJ. Serum carotenoids 
and oxidative DNA damage in human lymphocytes. Carcinogenesis, (1998) 19, 
2159-2162. 
149. Boyle SP, Dobson VL, Duthie SJ, Hinselwood DC, Kyle JA, Collins AR. 
Bioavailability and efficiency of rutin as an antioxidant: a human 
supplementation study. Eur J Clin Nutr, (2000) 54, 774-782. 
150. Møller P, Vogel U, Pedersen A, Dragsted LO, Sandstrom B, Loft S. No effect 
of 600 grams fruit and vegetables per day on oxidative DNA damage and repair 
in healthy nonsmokers. Cancer Epidemiol Biomarkers Prev, (2003) 12, 1016-
1022. 
151. Guarnieri S, Loft S, Riso P, Porrini M, Risom L, Poulsen HE, Dragsted LO, 
Møller P. DNA repair phenotype and dietary antioxidant supplementation. Br J 
Nutr, (2008) 99, 1018-1024. 
  83 
152. Møller P, Viscovich M, Lykkesfeldt J, Loft S, Jensen A, Poulsen HE. Vitamin 
C supplementation decreases oxidative DNA damage in mononuclear blood 
cells of smokers. Eur J Nutr, (2004) 43, 267-274.  
153. Duthie SJ, Ma A, Ross MA, Collins AR. Antioxidant supplementation 
decreases oxidative DNA damage in human lymphocytes. Cancer Res, (1996) 
56, 1291-1295. 
154. Rytter E, Johansson C, Vessby B, Sjödin A, Möller L, Åkesson B, Basu S. 
Biomarkers of oxidative stress in overweight men are not influenced by a 
combination of antioxidants. Free Radic Res, (2010) 44, 522-528. 
155. Rytter E, Vessby B, Åsgård R, Ersson C, Moussavian S, Sjödin A, Abramsson-
Zetterberg L, Möller L, Basu S. Supplementation with a combination of 
antioxidants does not affect glycaemic control, oxidative stress or inflammation 
in type 2 diabetes subjects. Free Radic Res, (2010) 44, 1445-1453. 
156. van den Berg R, van Vliet T, Broekmans WM, Cnubben NH, Vaes WH, Roza 
L, Haenen GR, Bast A, et al. A vegetable/fruit concentrate with high 
antioxidant capacity has no effect on biomarkers of antioxidant status in male 
smokers. J Nutr, (2001) 131, 1714-1722. 
157. Collins AR, Harrington V, Drew J, Melvin R. Nutritional modulation of DNA 
repair in a human intervention study. Carcinogenesis, (2003) 24, 511-515. 
158. Brevik A, Gaivao I, Medin T, Jorgenesen A, Piasek A, Elilasson J, Karlsen A, 
Blomhoff R, et al. Supplementation of a western diet with golden kiwifruits 
(Actinidia chinensis var.'Hort 16A':) effects on biomarkers of oxidation damage 
and antioxidant protection. Nutr J, (2011) 10, 54. 
159. Møller P, Loft S, Alfthan G, Freese R. Oxidative DNA damage in circulating 
mononuclear blood cells after ingestion of blackcurrant juice or anthocyanin-
rich drink. Mutat Res, (2004) 551, 119-126. 
160. Duthie SJ, Jenkinson AM, Crozier A, Mullen W, Pirie L, Kyle J, Yap LS, 
Christen P, Duthie GG. The effects of cranberry juice consumption on 
antioxidant status and biomarkers relating to heart disease and cancer in healthy 
human volunteers. Eur J Nutr, (2006) 45, 113-122. 
161. Riso P, Martini D, Visioli F, Martinetti A, Porrini M. Effect of broccoli intake 
on markers related to oxidative stress and cancer risk in healthy smokers and 
nonsmokers. Nutr Cancer, (2009) 61, 232-237. 
162. Riso P, Martini D, Møller P, Loft S, Bonacina G, Moro M, Porrini M. DNA 
damage and repair activity after broccoli intake in young healthy smokers. 
Mutagenesis, (2010) 25, 595-602. 
163. Brevik A, Karlsen A, Azqueta A, Tirado AE, Blomhoff R, Collins A. Both base 
excision repair and nucleotide excision repair in humans are influenced by 
nutritional factors. Cell Biochem Funct, (2011) 29, 36-42. 
164. Johansson C, Rytter E, Nygren J, Vessby B, Basu S, Möller L. Down-regulation 
of oxidative DNA lesions in human mononuclear cells after antioxidant 
supplementation correlates to increase of gamma-tocopherol. Int J Vitam Nutr 
Res, (2008) 78, 183-194. 
165. Hofer T, Möller L. Optimization of the workup procedure for the analysis of 8-
oxo-7,8-dihydro-2'-deoxyguanosine with electrochemical detection. Chem Res 
Toxicol, (2002) 15, 426-432. 
166. Basu S. Radioimmunoassay of 8-iso-prostaglandin F2alpha: an index for 
oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins 
Leukot Essent Fatty Acids, (1998) 58, 319-325. 
167. Öhrvall M, Tengblad S, Ekstrand B, Siegbahn A, Vessby B. Malondialdehyde 
concentration in plasma is inversely correlated to the proportion of linoleic acid 
in serum lipoprotein lipids. Atherosclerosis, (1994) 108, 103-110. 
  84 
168. Hofer T. Thesis: Method Development for Analysis of 8-oxodG as a Biomarker 
for Oxidative Stress. Stockholm, Karolinska Institutet, 2001. 
169. Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on 
malondialdehyde as toxic molecule and biological marker of oxidative stress. 
Nutr Metab Cardiovasc Dis, (2005) 15, 316-328. 
170. Dušinská M, Vallova B, Ursinyova M, Hladikova V, Smolkova B, Wsolova L, 
Raslova K, Collins AR. DNA damage and antioxidants; fluctuations through 
the year in a central European population group. Food Chem Toxicol, (2002) 
40, 1119-1123. 
171. Møller P, Knudsen LE, Frentz G, Dybdahl M, Wallin H, Nexo BA. Seasonal 
variation of DNA damage and repair in patients with non-melanoma skin 
cancer and referents with and without psoriasis. Mutat Res, (1998) 407, 25-34. 
172. Møller P, Wallin H, Holst E, Knudsen LE. Sunlight-induced DNA damage in 
human mononuclear cells. FASEB J, (2002) 16, 45-53. 
173. Tsilimigaki SI, Messini-Nikolaki N, Kanariou M, Piperakis SM. A study on the 
effects of seasonal solar radiation on exposed populations. Mutagenesis, (2003) 
18, 139-143. 
174. Dušinská M, Collins AR. DNA Oxidation, Antioxidant Effects, and DNA 
Repair Measured with the Comet Assay. In: Aldini G, Yeum KJ, Niki E, 
Russell RM (Eds). Biomarkers for Antioxidant Defense and Oxidative Damage: 
Principles and Practical Applications: Blackwell Publishing Ltd, 2010, pp. 
261-282. 
175. Hoelzl C, Knasmuller S, Misik M, Collins A, Dušinská M, Nersesyan A. Use of 
single cell gel electrophoresis assays for the detection of DNA-protective 
effects of dietary factors in humans: Recent results and trends. Mutat Res, 
(2009) 681, 68-79. 
176. Pouget JP, Ravanat JL, Douki T, Richard MJ, Cadet J. Measurement of DNA 
base damage in cells exposed to low doses of gamma-radiation: comparison 
between the HPLC-EC and comet assays. Int J Radiat Biol, (1999) 75, 51-58. 
177. Gedik CM, Wood SG, Collins AR. Measuring oxidative damage to DNA; 
HPLC and the comet assay compared. Free Radic Res, (1998) 29, 609-615. 
178. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in 
vivo and in cell culture: how should you do it and what do the results mean? Br 
J Pharmacol, (2004) 142, 231-255. 
179. Elmadfa I, Wagner KH. Non-nutritive bioactive food constituents of plants: 
tocopherols (vitamin E). Int J Vitam Nutr Res, (2003) 73, 89-94. 
180. Devaraj S, Leonard S, Traber MG, Jialal I. Gamma-tocopherol supplementation 
alone and in combination with alpha-tocopherol alters biomarkers of oxidative 
stress and inflammation in subjects with metabolic syndrome. Free Radic Biol 
Med, (2008) 44, 1203-1208. 
181. Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, Norkus EP, 
Morris JS, Comstock GW. Association between alpha-tocopherol, gamma-
tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst, 
(2000) 92, 2018-2023. 
182. Hensley K, Benaksas EJ, Bolli R, Comp P, Grammas P, Hamdheydari L, Mou 
S, Pye QN, et al. New perspectives on vitamin E: gamma-tocopherol and 
carboxyelthylhydroxychroman metabolites in biology and medicine. Free Radic 
Biol Med, (2004) 36, 1-15. 
183. Christen S, Woodall AA, Shigenaga MK, Southwell-Keely PT, Duncan MW, 
Ames BN. gamma-tocopherol traps mutagenic electrophiles such as NO(X) and 
complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci 
U S A, (1997) 94, 3217-3222. 
  85 
184. Cooney RV, Franke AA, Harwood PJ, Hatch-Pigott V, Custer LJ, Mordan LJ. 
Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-
tocopherol. Proc Natl Acad Sci U S A, (1993) 90, 1771-1775. 
185. Morton LW, Ward NC, Croft KD, Puddey IB. Evidence for the nitration of 
gamma-tocopherol in vivo: 5-nitro-gamma-tocopherol is elevated in the plasma 
of subjects with coronary heart disease. Biochem J, (2002) 364, 625-628. 
186. Saldeen T, Li D, Mehta JL. Differential effects of alpha- and gamma-tocopherol 
on low-density lipoprotein oxidation, superoxide activity, platelet aggregation 
and arterial thrombogenesis. J Am Coll Cardiol, (1999) 34, 1208-1215. 
187. Ferguson LR. Chronic inflammation and mutagenesis. Mutat Res, (2010) 690, 
3-11. 
188. Kline K, Lawson KA, Yu W, Sanders BG. Vitamin E and cancer. Vitam Horm, 
(2007) 76, 435-461. 
 
 
  

